
<html lang="en"     class="pb-page"  data-request-id="16c676ee-a171-4125-b7d9-d82a00d5406b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b01427;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-23;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)" /></meta><meta name="dc.Creator" content="Alison J.-A.  Woolford" /></meta><meta name="dc.Creator" content="Philip J.  Day" /></meta><meta name="dc.Creator" content="Véronique  Bénéton" /></meta><meta name="dc.Creator" content="Valerio  Berdini" /></meta><meta name="dc.Creator" content="Joseph E.  Coyle" /></meta><meta name="dc.Creator" content="Yann  Dudit" /></meta><meta name="dc.Creator" content="Pascal  Grondin" /></meta><meta name="dc.Creator" content="Pascal  Huet" /></meta><meta name="dc.Creator" content="Lydia Y. W.  Lee" /></meta><meta name="dc.Creator" content="Eric S.  Manas" /></meta><meta name="dc.Creator" content="Rachel L.  McMenamin" /></meta><meta name="dc.Creator" content="Christopher W.  Murray" /></meta><meta name="dc.Creator" content="Lee W.  Page" /></meta><meta name="dc.Creator" content="Vipulkumar K.  Patel" /></meta><meta name="dc.Creator" content="Florent  Potvain" /></meta><meta name="dc.Creator" content="Sharna J.  Rich" /></meta><meta name="dc.Creator" content="Yingxia  Sang" /></meta><meta name="dc.Creator" content="Don O.  Somers" /></meta><meta name="dc.Creator" content="Lionel  Trottet" /></meta><meta name="dc.Creator" content="Zehong  Wan" /></meta><meta name="dc.Creator" content="Xiaomin  Zhang" /></meta><meta name="dc.Description" content="Lp-PLA2 has been explored as a target for a number of inflammation associated diseases, including cardiovascular disease and dementia. This article describes the discovery of a new fragment derived..." /></meta><meta name="Description" content="Lp-PLA2 has been explored as a target for a number of inflammation associated diseases, including cardiovascular disease and dementia. This article describes the discovery of a new fragment derived..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 18, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01427" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01427" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01427" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01427" /></link>
        
    
    

<title>Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01427" /></meta><meta property="og:title" content="Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0024.jpeg" /></meta><meta property="og:description" content="Lp-PLA2 has been explored as a target for a number of inflammation associated diseases, including cardiovascular disease and dementia. This article describes the discovery of a new fragment derived chemotype that interacts with the active site of Lp-PLA2. The starting fragment hit was discovered through an X-ray fragment screen and showed no activity in the bioassay (IC50 &gt; 1 mM). The fragment hit was optimized using a variety of structure-based drug design techniques, including virtual screening, fragment merging, and improvement of shape complementarity. A novel series of Lp-PLA2 inhibitors was generated with low lipophilicity and a promising pharmacokinetic profile." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01427"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01427">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01427&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01427&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01427&amp;href=/doi/10.1021/acs.jmedchem.6b01427" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10738-10749</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01436" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01435" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alison+J.-A.++Woolford">Alison J.-A. Woolford</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+J.++Day">Philip J. Day</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=V%C3%A9ronique++B%C3%A9n%C3%A9ton">Véronique Bénéton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valerio++Berdini">Valerio Berdini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+E.++Coyle">Joseph E. Coyle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yann++Dudit">Yann Dudit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Grondin">Pascal Grondin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Huet">Pascal Huet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lydia+Y.+W.++Lee">Lydia Y. W. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+S.++Manas">Eric S. Manas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachel+L.++McMenamin">Rachel L. McMenamin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+W.++Murray">Christopher W. Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lee+W.++Page">Lee W. Page</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vipulkumar+K.++Patel">Vipulkumar K. Patel</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florent++Potvain">Florent Potvain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharna+J.++Rich">Sharna J. Rich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingxia++Sang">Yingxia Sang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Don+O.++Somers">Don O. Somers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lionel++Trottet">Lionel Trottet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zehong++Wan">Zehong Wan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaomin++Zhang">Xiaomin Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Centre de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Neurodegeneration DPU, GlaxoSmithKline, 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>(A.J.-A.W.) Tel: +44-0-1223 226283. E-mail: <a href="/cdn-cgi/l/email-protection#d293bebba1bdbcfc85bdbdbeb4bda0b692b3a1a6aafcb1bdbf"><span class="__cf_email__" data-cfemail="f8b994918b9796d6af9797949e978a9cb8998b8c80d69b9795">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>(V.K.P.) Tel: +44-0-1438 551281. E-mail: <a href="/cdn-cgi/l/email-protection#b5e3dcc5c0d99bfe9be5d4c1d0d9f5f2e6fe9bd6dad8"><span class="__cf_email__" data-cfemail="c395aab3b6afed88ed93a2b7a6af83849088eda0acae">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01427&amp;href=/doi/10.1021%2Facs.jmedchem.6b01427" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10738–10749</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 10, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 September 2016</li><li><span class="item_label"><b>Published</b> online</span>18 November 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 December 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01427" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01427</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10738%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlison%2BJ.-A.%2BWoolford%252C%2BPhilip%2BJ.%2BDay%252C%2BV%25C3%25A9ronique%2BB%25C3%25A9n%25C3%25A9ton%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D23%26contentID%3Dacs.jmedchem.6b01427%26title%3DFragment-Based%2BApproach%2Bto%2Bthe%2BDevelopment%2Bof%2Ban%2BOrally%2BBioavailable%2BLactam%2BInhibitor%2Bof%2BLipoprotein-Associated%2BPhospholipase%2BA2%2B%2528Lp-PLA2%2529%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10749%26publicationDate%3DDecember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01427"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1449</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01427" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alison&quot;,&quot;last_name&quot;:&quot;J.-A. Woolford&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;J. Day&quot;},{&quot;first_name&quot;:&quot;Véronique&quot;,&quot;last_name&quot;:&quot;Bénéton&quot;},{&quot;first_name&quot;:&quot;Valerio&quot;,&quot;last_name&quot;:&quot;Berdini&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;E. Coyle&quot;},{&quot;first_name&quot;:&quot;Yann&quot;,&quot;last_name&quot;:&quot;Dudit&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Grondin&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Huet&quot;},{&quot;first_name&quot;:&quot;Lydia&quot;,&quot;last_name&quot;:&quot;Y. W. Lee&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;S. Manas&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;L. McMenamin&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;W. Murray&quot;},{&quot;first_name&quot;:&quot;Lee&quot;,&quot;last_name&quot;:&quot;W. Page&quot;},{&quot;first_name&quot;:&quot;Vipulkumar&quot;,&quot;last_name&quot;:&quot;K. Patel&quot;},{&quot;first_name&quot;:&quot;Florent&quot;,&quot;last_name&quot;:&quot;Potvain&quot;},{&quot;first_name&quot;:&quot;Sharna&quot;,&quot;last_name&quot;:&quot;J. Rich&quot;},{&quot;first_name&quot;:&quot;Yingxia&quot;,&quot;last_name&quot;:&quot;Sang&quot;},{&quot;first_name&quot;:&quot;Don&quot;,&quot;last_name&quot;:&quot;O. Somers&quot;},{&quot;first_name&quot;:&quot;Lionel&quot;,&quot;last_name&quot;:&quot;Trottet&quot;},{&quot;first_name&quot;:&quot;Zehong&quot;,&quot;last_name&quot;:&quot;Wan&quot;},{&quot;first_name&quot;:&quot;Xiaomin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;10738-10749&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01427&quot;},&quot;abstract&quot;:&quot;Lp-PLA2 has been explored as a target for a number of inflammation associated diseases, including cardiovascular disease and dementia. This article describes the discovery of a new fragment derived chemotype that interacts with the active site of Lp-PLA2. The starting fragment hit was discovered through an X-ray fragment screen and showed no activity in the bioassay (IC50 &gt; 1 mM). The fragment hit was optimized using a variety of structure-based drug design techniques, including virtual screening, fragment merging, and improvement of shape complementarity. A novel series of Lp-PLA2 inhibitors was generated with low lipophilicity and a promising pharmacokinetic profile.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01427&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01427" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01427&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01427" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01427&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01427" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01427&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01427&amp;href=/doi/10.1021/acs.jmedchem.6b01427" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01427" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01427" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01427%26sid%3Dliteratum%253Aachs%26pmid%3D27933945%26genre%3Darticle%26aulast%3DWoolford%26date%3D2016%26atitle%3DFragment-Based%2BApproach%2Bto%2Bthe%2BDevelopment%2Bof%2Ban%2BOrally%2BBioavailable%2BLactam%2BInhibitor%2Bof%2BLipoprotein-Associated%2BPhospholipase%2BA2%2B%2528Lp-PLA2%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D23%26spage%3D10738%26epage%3D10749%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292288" title="X-rays">X-rays</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/jmcmar.2016.59.issue-23/20161208/jmcmar.2016.59.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Lp-PLA<sub>2</sub> has been explored as a target for a number of inflammation associated diseases, including cardiovascular disease and dementia. This article describes the discovery of a new fragment derived chemotype that interacts with the active site of Lp-PLA<sub>2</sub>. The starting fragment hit was discovered through an X-ray fragment screen and showed no activity in the bioassay (IC<sub>50</sub> > 1 mM). The fragment hit was optimized using a variety of structure-based drug design techniques, including virtual screening, fragment merging, and improvement of shape complementarity. A novel series of Lp-PLA<sub>2</sub> inhibitors was generated with low lipophilicity and a promising pharmacokinetic profile.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lp-PLA<sub>2</sub> is a member of the phospholipase A2 superfamily, which specifically cleave the <i>sn</i>-2 ester bond of glycerophospholipids.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Lp-PLA<sub>2</sub> is found in the plasma and circulates in complex to high and low density lipoproteins.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The biological substrate(s) for this lipase are unknown, but studies examining the hydrolysis of a variety of <i>sn</i>-2 acyl chain lengths have shown that Lp-PLA<sub>2</sub> hydrolyses oxidized and truncated phospholipids.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Cleavage of oxidatively damaged phospholipid substrates releases pro-inflammatory factors such as lysophosphatidylcholine and oxidized nonesterified fatty acids,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> which can lead to inflammation in the arteries and cardiovascular disease (CVD).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, Lp-PLA<sub>2</sub> is a pro-inflammatory, lipid-modifying, enzyme. The plasma levels of Lp-PLA<sub>2</sub> have been shown to correlate with CVD, and Lp-PLA<sub>2</sub> is now an established biomarker. Other diseases that have elevated levels of Lp-PLA<sub>2</sub> include dementia,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> diabetic macular edema,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and prostate cancer.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Inhibitors of Lp-PLA<sub>2</sub> have been investigated in the clinic for atherosclerosis<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Alzheimer’s disease.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> For example, darapladib (<b>1</b>) is an orally bioavailable and very potent inhibitor of Lp-PLA<sub>2</sub> with IC<sub>50</sub> = 49 pM in a biochemical assay.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A secondary “plasma” assay measures inhibition in whole plasma, which approximates the physiological environment of the enzyme, and darapladib has an IC<sub>50</sub> = 35 nM.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Darapladib has undergone two phase three trials for cardiovascular disease but has been discontinued because it did not meet the primary end points. Several other classes of inhibitors have been reported in the literature, but none has yet progressed to the clinic.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0025.gif" alt="" id="fx1" /></img></div><div class="NLM_p">The crystal structures of apo Lp-PLA<sub>2</sub><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and its complex with darapladib<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> have previously been reported. Lp-PLA<sub>2</sub> exhibits the classic lipase α/β-hydrolase fold with a catalytic triad comprising Ser273, His351, and Asp296 adjacent to an oxyanion hole formed by the backbone NH’s of both Leu153 and Phe274. A water molecule occupies the oxyanion hole in apo Lp-PLA<sub>2</sub> but is displaced by the pyrimidone carbonyl of darapladib which forms the same two H-bonds to Leu153 and Phe274 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a). The biaryl rings in darapladib stack upon the fluorophenyl in a hydrophobic collapse, and together, they fill the lipophilic groove marked by the residues Phe110 and Phe357.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The (2-aminoethyl)diethylamine moiety is mainly solvent exposed and is important for the solubility and pharmacokinetic properties of the molecule.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) X-ray crystal structure of darapladib (<b>1</b>) bound to Lp-PLA<sub>2</sub>. The Connolly surface of darapladib is shown in solid purple and the protein as a gray mesh. (b) Superposition of the X-ray crystal structures of uracil <b>2</b> (cyan), hydantoin <b>3</b> (magenta), and sulfonamide <b>4</b> (green) bound to Lp-PLA<sub>2</sub>. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PLA2-VIIB is a closely related intracellular phospholipase.<a onclick="showRef(event, 'cit1a ref15'); return false;" href="javascript:void(0);" class="ref cit1a ref15">(1a, 15)</a> The catalytic sites of Lp-PLA<sub>2</sub> and PLA2-VIIB are highly conserved, but in the adjoining groove, there are a number of differences including Phe110 (Lp-PLA<sub>2</sub>)/Tyr65 (PLA2-VIIB), Gln352 (Lp-PLA<sub>2</sub>)/Arg315 (PLA2-VIIB), and Ala355 (Lp-PLA<sub>2</sub>)/Thr318 (PLA2-VIIB). Darapladib (<b>1</b>) possesses a 1200-fold selectivity for Lp-PLA<sub>2</sub> over PLA2-VIIB and makes van der Waals contacts with the side chains of these residues.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">One of the goals for this project was to identify novel chemotypes that had comparable activity in the plasma assay to darapladib. We reasoned that if we were able to achieve a significant decrease in the drop off between the Lp-PLA<sub>2</sub> biochemical and plasma assays, the lead compound does not need to be picomolar in the biochemical assay. Therefore, the lead compound could have lower molecular weight (MW) and more reasonable lipophilicity than darapladib (MW = 667, clogP<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> = 8.3). Literature has shown that aspiring to keep the physicochemical properties within guidelines is desirable (i.e., MW < 500 and clogP < 5) through association with increased success in the clinic.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, optimization against the plasma potency should not be performed without a parallel consideration of in vivo parameters, and we therefore looked to achieve good pharmacokinetic properties.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, we wished to retain greater than 100-fold selectivity against PLA2-VIIB. We chose to use fragment based technology to meet these goals, as this approach can facilitate tighter control of physicochemical properties.</div><div class="NLM_p">Our fragment screen methodology and output have been reported previously.<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> Crystal structures for 50 fragment hits were obtained and were observed to bind throughout the entire length of the canyon-like groove of Lp-PLA<sub>2</sub> occupying a total length of ∼24 Å.</div><div class="NLM_p">The X-ray crystal structures of three compounds (<b>2</b>–<b>4</b>) bound to Lp-PLA<sub>2</sub> are superimposed in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b (and shown separately in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). These compounds occupy different regions of the binding site and recapitulate many of the key binding interactions of darapladib.<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> Hydantoin <b>3</b> (IC<sub>50</sub> > 1 mM)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was perceived to be an attractive starting point. It is a small fragment (heavy atom count = 10) that is synthetically accessible with excellent vectors for exploring the binding pocket. Uracil <b>2</b> (IC<sub>50</sub> ∼ 1 mM)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and sulfonamide <b>4</b> (IC<sub>50</sub> ∼ 1 mM)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> showed potential areas to gain binding affinity, for example, hydrogen bonds to Gln352 (side chain), Leu153 (backbone carbonyl), Leu369 (backbone carbonyl), Phe357 (backbone NH), and lipophilic/π-stacking interactions with the indolyl of Trp298. This article will disclose how we evolved hydantoin <b>3</b>, using insights from uracil <b>2</b> and sulfonamide <b>4</b>, to generate novel low MW inhibitors of Lp-PLA<sub>2</sub> with a promising PK profile.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structures of compounds <b>2</b>–<b>4</b> bound to Lp-PLA<sub>2</sub>; uracil <b>2</b> (cyan) is a fragment hit that binds adjacent to the catalytic residues Ser273, His351, and Asp296; hydantoin <b>3</b> (magenta) is a fragment hit that is bound in the oxyanion hole; and sulfonamide <b>4</b> (green) is derived from a fragment hit.<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> The Connolly surface of the protein is shown as a gray mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines, and water is shown as gray spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Hydantoin Optimization</h3><div class="NLM_p">Hydantoin <b>3</b> (clogP = 0.03) did not show any activity in the biochemical assay and was only discovered through an X-ray crystallographic screen. The crystal structure shows that the fragment occupies the oxyanion hole of Lp-PLA<sub>2</sub> with two hydrogen bonds to the backbone NH of both Leu153 and Phe274 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b).</div><div class="NLM_p">The overall strategy to develop hydantoin <b>3</b> into a potent inhibitor is illustrated in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. It began by overlaying the crystal structures of hydantoin <b>3</b> and sulfonamide <b>4</b> bound to Lp-PLA<sub>2</sub> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b). These two compounds map out the very bottom of the pocket, and a narrow channel is present between the NH of hydantoin <b>3</b> and phenyl ring of sulfonamide <b>4</b>. Merging these motifs with a suitable linker should simultaneously increase potency and lipophilicity of the hydantoin template. The predicted clash between the sulfonamide oxygen and hydantoin carbonyl precluded directly linking the two fragments. We employed a virtual screening (VS) strategy to investigate a variety of linkers to grow from hydantoin <b>3</b> to areas of known potency (such as regions occupied by uracil <b>2</b>, sulfonamide <b>4</b>, and darapladib).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic design process. Moieties within the compounds are colored according to the original compound from which they are derived. a: rhLp-PLA<sub>2</sub> PED6 assay. b: rhLp-PLA<sub>2</sub> Thio-PAF assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substructure screening identified ∼16,000 hydantoins from in-house and commercially available compounds. This library was filtered on molecular weight (MW < 300), and docking runs were performed against in-house Lp-PLA<sub>2</sub> crystal structures using the Astex proprietary version of Gold software.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A total of 33 hits were subsequently screened using X-ray crystallography and biochemical assays. This method quickly identified hydantoin <b>5</b> with an IC<sub>50</sub> = 14 μM.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The crystal structure of hydantoin <b>5</b> bound in Lp-PLA<sub>2</sub> is shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. The hydantoin forms the expected two H-bonds in the oxyanion hole, and the ethoxy linker places the phenyl ring into a deep pocket terminated by residue Phe357. The cyclohexyl ring sits in a predominantly lipophilic groove surrounded by the side chains of Leu153, Trp298, and Phe322.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of hydantoin <b>5</b> bound in Lp-PLA<sub>2</sub>. The Connolly surface of the ligand is shown in solid orange and the protein as a gray mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although hydantoin <b>5</b> was a reasonably ligand efficient lead with LE = 0.30,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> we decided to strip back the cyclohexyl ring and optimize the hydantoin motif (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Hydantoin <b>6</b> was designed to retain the <i>N</i>-methyl (from hydantoin <b>3</b>) and the ethoxy linker (from hydantoin <b>5</b>), and was only weakly active at IC<sub>50</sub> ∼1 mM.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Addition of the gem-dimethyl in hydantoin <b>7</b> gave a ∼50-fold increase in potency to IC<sub>50</sub> = 20 μM<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (LE = 0.34) and demonstrated that the branched nature of the gem-dimethyl was important. Incorporation of the 4-fluoro in hydantoin <b>8</b> gave a modest 2-fold increase in affinity and retained the LE at 0.34. Systematic exploration of the hydantoin ring by removing the <i>N</i>-methyl (<b>9</b>), and then replacing the amide carbonyl with methylene (<b>10</b>), did not yield an improvement in LE over hydantoin <b>8</b>. However, replacing the NH by methylene to give γ-lactam <b>11</b> resulted in a more ligand efficient template (LE = 0.38). Ring expansion was also tolerated and yielded δ-lactam <b>12</b> with similar potency (IC<sub>50</sub> = 10 μM;<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> LE = 0.36).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure-Based Optimization of Hydantoin <b>5</b><a class="ref internalNav" href="#t1fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table *</sup><p class="last">All assay details are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t1fn2"><sup>Table a</sup><p class="last">Recombinant human Lp-PLA<sub>2</sub> PED6 assay. The main Lp-PLA<sub>2</sub> bioassay used a Thio-Paf substrate, but the assay format was unsuitable for weakly binding compounds (∼50 μM or weaker). A PED6 fluorogenic substrate was employed for the weaker inhibitors. These two primary bioassays correlated well across many compounds (data not shown).</p></div><div class="footnote" id="t1fn3"><sup>Table b</sup><p class="last">Recombinant human Lp-PLA<sub>2</sub> Thio-PAF assay.</p></div><div class="footnote" id="t1fn4"><sup>Table c</sup><p class="last">Recombinant human PLA2-VIIB Thio-PAF assay.</p></div></div><div></div></div><div class="NLM_p">The crystal structure of sulfonamide <b>4</b> bound in Lp-PLA<sub>2</sub> indicates that the cyano fills a small pocket formed by Phe357, Ala355, the side chain of Leu159, and a water molecule (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). The cyano also forms a long H-bond to the backbone NH of Phe357. When the X-ray crystal structures of sulfonamide <b>4</b> or hydantoin <b>5</b> bound to Lp-PLA<sub>2</sub> are overlaid, both phenyl rings reside in the same position. We therefore substituted a cyano in the equivalent position on the lactam series leading to the design of lactam <b>13</b>, which had an IC<sub>50</sub> = 3.0 μM<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and an ITC <i>K</i><sub>d</sub> = 2.0 μM. This compound was potent enough to be characterized in the main Thio-Paf biochemical assay and had an IC<sub>50</sub> = 15 μM<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, footnote a).</div><div class="NLM_p">The crystal structure of lactam <b>13</b> in complex with Lp-PLA<sub>2</sub> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) gave the expected binding mode and the cyano fills the small subpocket. The gem-dimethyl motif in lactam <b>13</b> provides excellent complementarity to the pocket and completely fills the groove between the side chains of Leu153, Trp298, and Phe322. The ether oxygen in <b>13</b> is important to orientate the phenyl ring into the pocket lined with Phe110, Ala355, and Phe357 and also forms a close contact with the side chain of Gln352. The residues Phe110, Gln352, and Ala355 are significant because they are replaced in PLA2-VIIB by Tyr, Arg, and Thr, respectively. Lactam <b>13</b> shows good selectivity over PLA2-VIIB, and this template became our lead for further optimization.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of lactam <b>13</b> in complex with Lp-PLA<sub>2</sub>. The Connolly surface of the ligand is shown as an orange mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines, and a water molecule is shown as a gray sphere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Growth of Lactam <b>13</b></h3><div class="NLM_p">The gem-dimethyl in lactam <b>13</b> makes contact with the indolyl of Trp298 and fills a lipophilic space between the side chains of Leu153 and Phe322. Uracil <b>2</b> occupies a similar region and stacks on the indolyl of Trp298. We therefore designed lactam <b>(±)-14</b> to mimic this interaction by substituting a phenyl ring from the C-4 position on the lactam (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) and designed further analogues with an additional methyl (enantiomers <b>(</b><i><b>S</b></i><b>)-15</b> and <b>(</b><i><b>R</b></i><b>)-15</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure-Based Optimization of Lactam <b>13</b><a class="ref internalNav" href="#t2fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table *</sup><p class="last">All assay details are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t2fn2"><sup>Table a</sup><p class="last">Recombinant human Lp-PLA<sub>2</sub> Thio-PAF assay.</p></div><div class="footnote" id="t2fn3"><sup>Table b</sup><p class="last">Recombinant human PLA2-VIIB Thio-PAF assay.</p></div><div class="footnote" id="t2fn4"><sup>Table c</sup><p class="last">Chirality of the stereocenter has been confirmed by the X-ray crystal structure of the ligand bound to Lp-PLA<sub>2</sub>.</p></div></div><div></div></div><div class="NLM_p">Lactams <b>(±)-14</b>, <b>(</b><i><b>S</b></i><b>)-15</b>, and <b>(</b><i><b>R</b></i><b>)-15</b> all successfully gave an increase in potency of ∼15-fold and retained LE. Interestingly, the three analogues were approximately equipotent and in agreement with available ITC measurements (lactam <b>(</b><i><b>S</b></i><b>)-15</b>, <i>K</i><sub>d</sub> = 0.45 μM; and lactam <b>(</b><i><b>R</b></i><b>)-15</b>, <i>K</i><sub>d</sub> = 0.53 μM). <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> shows the superimposed binding modes of <b>(</b><i><b>S</b></i><b>)-15</b> and <b>(</b><i><b>R</b></i><b>)-15</b> in complex with Lp-PLA<sub>2</sub>. The unsubstituted phenyl rings both form edge-to-face stacking interactions with the indolyl of Trp298, and the multiple equipotent orientations of the phenyl rings are possible because the groove above Trp298 is wide and lipophilic. Addition of substituents to the phenyl ring or replacement by heterocycles (such as pyridine) did not significantly increase the potency (data not shown), and we sought a better solution to gain potency in this region.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Superposition of the X-ray crystal structures of lactams <b>(</b><i><b>S</b></i><b>)-15</b> (green) and <b>(</b><i><b>R</b></i><b>)-15</b> (orange), each in complex with Lp-PLA<sub>2</sub>. The Connolly surfaces of the ligands are shown as a mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Alongside aromatic substitutions (lactams <b>(±)-14</b>, <b>(</b><i><b>S</b></i><b>)-15</b>, and <b>(</b><i><b>R</b></i><b>)-15</b>), we also tried to grow from the template using alkyl groups. A series of compounds were synthesized where we introduced methyl groups to the gem-dimethyl moiety in lactam <b>13</b> in order to explore the groove above Trp298 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Lactam <b>(±)-16</b> gave an 8-fold increase in potency to an IC<sub>50</sub> = 2.0 μM. Separation of the enantiomers gave lactams <b>(</b><i><b>S</b></i><b>)-16</b> and <b>(</b><i><b>R</b></i><b>)-16</b>. These enantiomers had a low eudysmic ratio (ratio of these potencies) of 2 and again showed the pocket could accommodate both isomers. Removing the lactam C-4 methyl to generate the <i>i</i>-propyl in <b>(±)-17</b> gave an equipotent analogue and slightly increased the LE. This LE was maintained by further substitution of the <i>i</i>-propyl to give the <i>t</i>-butyl <b>(±)-18</b> (IC<sub>50</sub> = 0.98 μM, LE = 0.37). The crystal structure of <b>(±)-18</b> in Lp-PLA<sub>2</sub> showed the binding mode was consistent with previous analogues and the <i>t</i>-butyl sits in the Leu153, Trp298, and Phe322 groove (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure-Based Optimization of Lactam <b>13</b><a class="ref internalNav" href="#t3fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0018.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0019.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table *</sup><p class="last">All assay details are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t3fn2"><sup>Table a</sup><p class="last">Recombinant human Lp-PLA<sub>2</sub> Thio-PAF assay.</p></div><div class="footnote" id="t3fn3"><sup>Table b</sup><p class="last">Lp-PLA<sub>2</sub> in whole human plasma Thio-PAF assay.</p></div><div class="footnote" id="t3fn4"><sup>Table c</sup><p class="last">Recombinant human PLA2-VIIB Thio-PAF assay.</p></div><div class="footnote" id="t3fn5"><sup>Table d</sup><p class="last">Chirality of the stereocenter has been confirmed from the X-ray crystal structure of the ligand bound to Lp-PLA<sub>2</sub>.</p></div><div class="footnote" id="t3fn6"><sup>Table e</sup><p class="last">Formate salt.</p></div></div><div></div></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystal structure of Lp-PLA<sub>2</sub> in complex with the (<i>S</i>)-enantiomer of <b>(±)-18</b>. The Connolly surface of the ligand is shown in solid orange and the protein as a gray mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We felt the interactions between the <i>t</i>-butyl in <b>(±)-18</b> with the side chains of Trp298, Leu153, and Phe322 might be improved by cyclizing into a ring. We initially chose a piperidine ring where the NH group would point toward the solvent and allow modulation of physicochemical properties of the molecule. The basic moiety in lactam <b>(±)-19</b> was tolerated and had an IC<sub>50</sub> = 0.62 μM.</div><div class="NLM_p">Lactams <b>13</b>–<b>19</b> were selective over PLA2-VIIB (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) and all had IC<sub>50</sub> > 100 μM. These compounds also showed good activity in the plasma assay, and the drop off between the Lp-PLA<sub>2</sub> assay and the plasma assay remained extremely low (≤5-fold). This represented a significant improvement over darapladib (710-fold ratio, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). We attributed this result to the relatively low lipophilicity of this series (clogP ≤ 3.4), and the chromLogD<sub>7.4</sub> of lactam <b>(±)-19</b> was measured to be 1.5. Lactam <b>(±)-19</b> became our lead template for further exploration and assessment of the PK profile of the series.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure-Based Optimization of Lactam <b>(±)-19</b><a class="ref internalNav" href="#t4fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0020.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0021.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table *</sup><p class="last">All assay details are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t4fn2"><sup>Table a</sup><p class="last">Recombinant human Lp-PLA<sub>2</sub> Thio-PAF assay.</p></div><div class="footnote" id="t4fn3"><sup>Table b</sup><p class="last">Lp-PLA<sub>2</sub> in whole human plasma Thio-PAF assay.</p></div><div class="footnote" id="t4fn4"><sup>Table c</sup><p class="last">Recombinant human PLA2-VIIB Thio-PAF assay.</p></div><div class="footnote" id="t4fn5"><sup>Table d</sup><p class="last">Formate salt.</p></div><div class="footnote" id="t4fn6"><sup>Table e</sup><p class="last">Chirality of the stereocenter is inferred from the X-ray crystal structure of the eutomer from the racemic mixture bound to Lp-PLA<sub>2</sub>.</p></div><div class="footnote" id="t4fn7"><sup>Table f</sup><p class="last">Chirality of the stereocenter has been confirmed by the X-ray crystal structure of the ligand bound to Lp-PLA<sub>2</sub> and agrees with the crystal structure of the eutomer from the racemic mixture bound to Lp-PLA<sub>2</sub>.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Optimization of <b>(±)-19</b></h3><div class="NLM_p">The secondary amine <b>(±)-19</b> had a potency of IC<sub>50</sub> = 0.62 μM and comparable activity in the plasma assay. The amino group of the piperidine is too far away from the indolyl face of Trp298 to form a productive cation-π interaction, and so we explored alternatives. Exchanging the amine for an ether gave lactam <b>(±)-20</b>, which is an uncharged analogue at physiological pH and showed a 4-fold increase in potency in the Lp-PLA<sub>2</sub> bioassay. Acylation of the amine <b>(±)-19</b> to give amide <b>(±)-21</b> did not yield further potency, but interestingly, methylation to the tertiary amine <b>(±)-22</b> improved the potency by 8-fold to IC<sub>50</sub> = 0.075 μM. The enantiomers were chirally separated to give <b>(</b><i><b>S</b></i><b>)-22</b> and <b>(</b><i><b>R</b></i><b>)-22</b>, which had IC<sub>50</sub> of 0.072 μM and 2.7 μM, respectively. The eudysmic ratio is now 38, and this is significantly higher than the ratio of ∼2 for the previous pairs (i.e., <b>(</b><i><b>S</b></i><b>)-15</b>/<b>(</b><i><b>R</b></i><b>)-15</b>, and <b>(</b><i><b>S</b></i><b>)-16</b>/<b>(</b><i><b>R</b></i><b>)-16</b>). The (<i>R</i>)-enantiomer of <b>22</b> is the distomer (the less active isomer), and although the compound is accommodated in the pocket, the interactions with the protein are inferior with respect to the (<i>S</i>)-enantiomer of <b>22</b>.</div><div class="NLM_p">Next, we chose to exchange the secondary amine in <b>(±)-19</b> for a sulfone (<b>(±)-23</b>). We rationalized that the electron withdrawing capability of the sulfone may polarize the adjacent CH’s which are in contact with the electron rich indolyl of Trp298 and improve the interaction. Sulfone <b>(±)-23</b> showed a small increase in potency (3-fold) in the Lp-PLA<sub>2</sub> assay but a larger increase in potency in the plasma assay to IC<sub>50</sub> = 110 nM (8-fold). The enantiomers <b>(</b><i><b>S</b></i><b>)-23</b> and <b>(</b><i><b>R</b></i><b>)-23</b> also showed a separation in potency in the Lp-PLA<sub>2</sub> assay (eudysmic ratio of 36), and the eutomer (more active isomer) <b>(</b><i><b>S</b></i><b>)-23</b> had an IC<sub>50</sub> = 120 nM. Lactam <b>(</b><i><b>S</b></i><b>)-23</b> is equipotent to darapladib in the plasma assay but with a vastly improved LE (LE = 0.38 for <b>(</b><i><b>S</b></i><b>)-23</b>, and LE = 0.22 for darapladib). Turning our attention back to the phenyl ring, we found that the cyano could be replaced by an equipotent fluorine (<b>(±)</b>-<b>24</b> and <b>(</b><i><b>S</b></i><b>)-24</b>).</div><div class="NLM_p">Throughout the optimization, selectivity over PLA2-VIIB was retained (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), and the ratio between the plasma assay and the Lp-PLA<sub>2</sub> Thio-Paf assay remained low (<4). Overall, the LE was maintained at 0.35–0.37 for this set of compounds (in the Lp-PLA<sub>2</sub> Thio-Paf assay).</div><div class="NLM_p">An important feature of the compounds in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> is the quaternary methyl group on the six-membered aliphatic ring. Comparison of <b>(±)-23</b> with the des-methyl sulfone <b>(±)-25</b> shows the methyl group engenders a 22-fold increase in potency. QM calculations exploring the torsional landscape around the bond joining the two saturated rings in <b>(±)-23</b> and <b>(±)-25</b> were performed and showed that both molecules possessed the same lowest energy conformation that is also observed in the bioactive conformation. Thus, the potency gain is presumably through significantly improved ligand–protein complementary in the Leu153, Trp298, and Phe322 groove. This methyl was only discovered by moving away from aromaticity and careful stepwise optimization of the gem-dimethyl moiety (<b>13</b>) into the <i>t</i>-butyl (<b>(±)-18</b>). By way of comparison, the cyano contributes a useful but less spectacular 4-fold increase in potency (comparing <b>(±)-23</b> and <b>(±)-26</b>). Contributions of different parts of sulfone <b>(±)-23</b> to potency are shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> together with their group efficiency (GE).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Each moiety analyzed has a good contribution to the potency, with the least group efficient moiety being the sulfone which occupies a region that is more solvent exposed.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Group efficiency (GE = kcal mol<sup>–1</sup> per non-hydrogen atom) schematic for compound <b>(±)-23</b> based on pairwise comparisons (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). GE ≥ 0.3 is considered desirable.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> shows the crystal structure of <b>(</b><i><b>S</b></i><b>)-23</b> bound in Lp-PLA<sub>2</sub> with the expected binding mode. <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>a superimposes the X-ray crystal structures of <b>(</b><i><b>S</b></i><b>)-23</b> in complex Lp-PLA<sub>2</sub> with compounds <b>2</b>–<b>4</b>, and <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>b superimposes the X-ray crystal structures of <b>(</b><i><b>S</b></i><b>)-23</b> and darapladib. Together, these figures show that compounds <b>2</b>–<b>4</b>, <b>(</b><i><b>S</b></i><b>)-23</b>, and darapladib (<b>1</b>) have common pharmacophore elements, such as the carbonyl that occupies the oxyanion hole and a phenyl ring that resides in the deep lipophilic pocket beside Phe357. Additionally, sulfone <b>(</b><i><b>S</b></i><b>)-23</b> has efficiently utilized the space along the bottom of the pocket between Trp298 and Phe357 that was contacted by compounds <b>2</b>–<b>4</b>; in particular, we exploited the groove above Trp298 (which was not utilized by darapladib) to improve potency and simultaneously modulate the physicochemical properties of the ligand. Finally, we avoided using areas that were less likely to yield potency such as the region occupied by the (2-aminoethyl)diethylamine moiety in darapladib.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray crystal structure of Lp-PLA<sub>2</sub> in complex with lactam <b>(</b><i><b>S</b></i><b>)-23</b>. The Connolly surface of the ligand is shown in solid orange and the protein as a gray mesh. Selected residues are shown for clarity. Hydrogen bond interactions are represented as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Superposition of the X-ray crystal structures of uracil <b>2</b> (cyan), hydantoin <b>3</b> (magenta), sulfonamide <b>4</b> (green) (only showing the Connolly surface as a mesh), and <b>(</b><i><b>S</b></i><b>)-23</b> (orange), bound in Lp-PLA<sub>2</sub>. (b) Superposition of the crystal structures of <b>(</b><i><b>S</b></i><b>)-23</b> (orange) and darapladib (purple) bound in Lp-PLA<sub>2</sub>. Only selected residues are shown for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> PK Discussion</h3><div class="NLM_p">Lactams <b>(±)-19</b>, <b>(±)-22</b>, <b>(</b><i><b>S</b></i><b>)-23</b>, and <b>(</b><i><b>S</b></i><b>)-24</b> are all low MW (<400 MW) compounds, with solubilities >240 μM in the CLND assay (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>); in particular, <b>(</b><i><b>S</b></i><b>)-23</b> was measured by quantitative NMR to be fully soluble at 3.5 mM. The plasma protein binding (PPB) in both rats and dogs are extremely low for these compounds and helps to explain why the drop off between the Lp-PLA<sub>2</sub> assay and the plasma assay is so small (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The series does not show significant inhibition of the CYP450s 1A2, 3A4, 2C9, 2C19, and 2D6, as exemplified by CYP450 3A4 data in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, where the compounds have an IC<sub>50</sub> > 50 μM. However, there is a difference between the compounds in the permeability assay where the secondary amine <b>(±)-19</b> is poor, but the tertiary amine <b>(±)-22</b> and sulfones <b>(</b><i><b>S</b></i>)-23 and (<i><b>S</b></i><b>)-24</b> perform better. Assessment of the stability of <b>(±)-23</b> in rat blood showed the compound was 100% stable.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Profile for Key Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0022.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">3–6 replicates tested at 10 μM.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Inhibition of CYP3A4, ≥ 2 replicates.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">HCl salt.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">(<i>R</i>)-enantiomer tested.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">Measured at pH 7.4.</p></div><div class="footnote" id="t5fn6"><sup>Table f</sup><p class="last">Measured at pH 7.05.</p></div></div><div></div></div><div class="NLM_p">The secondary amine <b>(±)-19</b> is a low in vivo clearance compound in rats (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) with a reasonable volume of distribution (<i>Vss</i>) and half-life (<i>T</i><sub>1/2</sub>); this is in part attributed to the basic center in the molecule. However, amine <b>(±)-19</b> has poor permeability in the PAMPA assay which translates into an extremely low bioavailability. In contrast, the tertiary amine <b>(±)-22</b> is a moderate clearance compound (Cl = 24 mL/min/kg), and its superior permeability leads to good oral bioavailability (% <i>F</i> = 52%).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vivo Profile of Key Compounds in Rats and Dogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0023.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">In rats, HCl salt.</p></div></div><div></div></div><div class="NLM_p">Sulfone <b>(</b><i><b>S</b></i><b>)-23</b> has a low intrinsic clearance of 1.1 mL/min/g in rat liver microsomes. Unfortunately, this does not translate in vivo where it shows a much higher clearance of 67 mL/min/kg (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). However, modulation of the rat clearance is possible as demonstrated by sulfone <b>(±)-24</b>.</div><div class="NLM_p last">When assessed in dogs, the PK profiles of <b>(±)-22</b> and <b>(</b><i><b>S</b></i><b>)-23</b> look similar, and they are both low clearance compounds (8.6 and 11 mL/min/kg, respectively). <b>(±)-22</b> shows good oral bioavailability (% <i>F</i> = 76%), although it has a shorter half-life than desired. Overall, the series shows a promising profile and provides a suitable starting point for further lead optimization.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis</h3><div class="NLM_p">Synthesis of sulfone <b>(±)-23</b> is laid out in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, and followed the convergent strategy which involved a late stage alkylation of 2-pyrroldinone <b>(±)-30</b> with methanesulfonate <b>32</b>. Construction of 2-pyrroldinone <b>(±)-30</b> was central to this synthesis and was generated in four steps from commercially available thiane-4-carbaldehyde (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Thiane-4-carbaldehyde was methylated with MeI and NaH to generate the quaternary carbon center in <b>27</b>. This was followed by a Horner–Wadsworth–Emmons reaction with triethyl phosphonoacetate and <i>t</i>-BuOK to give (<i>E</i>)-unsaturated ester <b>28</b>. Nitromethane was reacted with the conjugated ester through a Michael addition to generate γ-nitro ester <b>(±)-29</b>. The nitro group was then selectively reduced with NiCl<sub>2</sub> and NaBH<sub>4</sub>, and in situ cyclization of the resulting γ-amino ester directly afforded 2-pyrrolidone <b>(±)-30</b>.</div><figure id="sch1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lactam Intermediate <b>(±)-31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeI, <i>t</i>-BuOK, THF, 0 °C, 2 h, 94%; (b) triethyl phosphonoacetate, <i>t</i>-BuOK, THF, 0 °C, 3 h, 96%; (c) nitromethane, 1,1,3,3-tetramethylguanidine, 100 °C (microwave), 4 h, 43%; (d) NiCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH, 0 °C, 1.5 h, 65%.</p></p></figure><div class="NLM_p">Methanesulfonate <b>32</b> was prepared in two steps from the commercially available 2-fluoro-5-hydroxybenzonitrile (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). 2-Fluoro-5-hydroxybenzonitrile was coupled with ethylene carbonate in the presence of K<sub>2</sub>CO<sub>3</sub> to give alcohol <b>31</b> in high yield. This was treated with methanesulfonyl chloride and triethylamine to give methanesulfonate <b>32</b>. Alkylation of 2-pyrrolidine <b>(±)-30</b> with <b>32</b> proceeded smoothly at elevated temperatures to afford sulfide <b>(±)-33</b> in 44% yield. Finally, oxidation of <b>(±)-33</b> with mCPBA gave sulfone <b>(±)-23</b>.</div><figure id="sch2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfone <b>(±)-23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethylene carbonate, K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C, 18 h, 92%; (b) Ms-Cl, Et<sub>3</sub>N, THF, 0 °C, 0.5 h, 88%; (c) NaH, DMF, 40 °C, 18 h, 44%; (d) mCPBA, DCM, 25 °C, 4 h, 66%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have discovered a new γ-lactam chemotype that binds in the oxyanion hole of Lp-PLA<sub>2</sub>, and which is distinct from the known pyrimidinone core. Previous inhibitors<a onclick="showRef(event, 'ref9 ref10 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref14">(9, 10, 14)</a> and analyses of the binding site<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> have suggested that obtaining potent, low lipophicity inhibitors could represent a significant challenge. Using a fragment-based approach, we have identified sulfone <b>(</b><i><b>S</b></i><b>)-23</b>, which shows a similar potency in plasma to darapladib but has significantly lower MW and is less lipophilic.</div><div class="NLM_p last">The design began with a hydantoin fragment that represented a novel chemotype for interacting with the oxyanion hole. Analysis of other diverse fragments that bound near the oxyanion hole was used to guide a virtual screening approach. This identified hydantion <b>5</b>, which contained two pharmacophore elements (the hydantoin carbonyl and a phenyl ring) joined by an ethoxy linker. Simplification of compound <b>5</b> and further optimization of the hydantoin motif generated the more ligand efficient γ-lactam <b>11</b>. Subsequent stepwise growth of the lactam into the Trp298 groove allowed us to further optimize ligand–protein interactions and discover a key methyl that was essential for potency. The resulting sulfone <b>(</b><i><b>S</b></i><b>)-23</b> is an alternative low MW, potent, and selective inhibitor for Lp-PLA<sub>2</sub> with attractive PK properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">Compounds <b>2</b>–<b>5</b> are commercially available. General directions are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The synthesis and characterization of sulfones <b>(±)-23</b>, <b>(</b><i><b>S</b></i><b>)-23</b>, and <b>(</b><i><b>R</b></i><b>)-23</b> are described below. A full description of the synthetic protocols and chemical characterizations for compounds <b>2</b>–<b>22</b> and <b>24</b>–<b>26</b> can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The purity of each compound was analyzed by HPLC–MS (ESI) and is >95%, unless otherwise stated.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Synthesis of 2-Fluoro-5-{2-[4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(±)-23</b>), 2-Fluoro-5-{2-[(4<i>R</i>)-4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(</b><i><b>R</b></i><b>)-23</b>), and 2-Fluoro-5-{2-[(4<i>S</i>)-4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(</b><i><b>S</b></i><b>)-23</b>)</h4><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 2-Fluoro-5-{2-[4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(±)-23</b>)</h5><div class="NLM_p">A mixture of 4-(4-methylthian-4-yl)pyrrolidin-2-one (<b>(±)-30</b>) (1000 mg, 5.02 mmol) and 2-(3-cyano-4-fluorophenoxy)ethylmethanesulfonate (<b>32</b>) (1951 mg, 7.53 mmol) were stirred in DMF (8 mL). NaH (502 mg, 12.5 mmol, 60% in mineral oil) was slowly added. The reaction was slowly warmed to 40 °C and stirred overnight. The reaction was quenched with water, and the product was extracted with EtOAc (×1). The organic layer was separated and then washed with brine and evaporated in vacuo. The crude product was purified by preparative TLC (100% EtOAc) to give 2-fluoro-5-{2-[4-(4-methylthian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(±)-33</b>) (800 mg, 44%). To 2-fluoro-5-{2-[4-(4-methylthian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(±)-33</b>) (250 mg, 0.690 mmol) was added 3-chloroperoxybenzoic acid (476 mg, 2.76 mmol) and DCM (5 mL). The reaction was stirred at 25 °C for 4 h. The reaction was quenched by the addition of sat. aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, and the product was extracted with EtOAc (×1). The organic layer was separated and washed with brine and evaporated in vacuo. The product was purified by preparative HPLC to yield 2-fluoro-5-{2-[4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(±)-23</b>) as a colorless solid (180 mg, 66%). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 7.36–7.32 (m, 1H), 7.32–7.26 (m, 2H), 4.19 (t, <i>J</i> = 5.3 Hz, 2H), 3.73 (dt, <i>J</i> = 14.6, 5.2 Hz, 1H), 3.68–3.57 (m, 2H), 3.49 (dd, <i>J</i> = 10.2, 7.4 Hz, 1H), 3.20–3.10 (m, 2H), 3.05–2.95 (m, 2H), 2.56 (app quin, <i>J</i> = 8.6 Hz, 1H), 2.42 (dd, <i>J</i> = 17.0, 9.1 Hz, 1H), 2.35 (dd, <i>J</i> = 17.0, 9.1 Hz, 1H), 2.04–1.94 (m, 2H), 1.89–1.80 (m, 2H), 1.04 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD): δ 175.3, 157.8 (d, <i>J</i> = 250.1 Hz), 154.9 (d, <i>J</i> = 2.2 Hz), 122.1 (d, <i>J</i> = 7.3 Hz), 117.7, 117.1 (d, <i>J</i> = 21.3 Hz), 113.2, 101.0 (d, <i>J</i> = 17.6 Hz), 66.3, 48.8, 46.4, 41.8, 39.7, 32.9, 32.7, 32.2, 31.6, 17.3. LCMS (method 2): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 412, RT = 1.25 min. Purity >95%. HRMS (ESI-QTOF): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>S is 395.1435; Found 395.1438 (Δ = 0.89 ppm).</div><div class="NLM_p last">The product was chirally separated by preparative-SFC to give 2-fluoro-5-{2-[(4<i>R</i>)-4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(</b><i><b>R</b></i><b>)-23</b>) as an off white solid (75 mg, 42% recovery) and 2-fluoro-5-{2-[(4<i>S</i>)-4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(</b><i><b>S</b></i><b>)-23</b>) as a colorless solid (78 mg, 43% recovery).</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 2-Fluoro-5-{2-[(4<i>S</i>)-4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(</b><i><b>S</b></i><b>)-23</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 7.36–7.32 (m, 1H), 7.32–7.26 (m, 2H), 4.19 (t, <i>J</i> = 5.3 Hz, 2H), 3.73 (dt, <i>J</i> = 14.6, 5.2 Hz, 1H), 3.68–3.57 (m, 2H), 3.48 (dd, <i>J</i> = 10.2, 7.5 Hz, 1H), 3.20–3.10 (m, 2H), 3.05–2.95 (m, 2H), 2.56 (app quint, <i>J</i> = 8.6 Hz, 1H), 2.42 (dd, <i>J</i> = 17.0, 9.1 Hz, 1H), 2.35 (dd, <i>J</i> = 17.0, 9.1 Hz, 1H), 2.04–1.94 (m, 2H), 1.89–1.79 (m, 2H), 1.04 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD): δ 175.3, 157.8 (d, <i>J</i> = 249.4 Hz), 154.9 (d, <i>J</i> = 2.2 Hz), 122.1 (d, <i>J</i> = 8.1 Hz), 117.7, 117.1 (d, <i>J</i> = 22.0 Hz), 113.2, 100.9 (d, <i>J</i> = 16.9 Hz), 66.3, 48.8, 46.4, 41.7, 39.7, 32.9, 32.7, 32.2, 31.6, 17.3. LCMS (method 2): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 412, RT = 1.24 min. Purity >95%. HRMS (ESI-QTOF): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>S is 395.1435; found, 395.1430 (Δ = −1.25 ppm). <i>ee</i> > 99%. Chirality of the stereocenter has been confirmed by the X-ray crystal structure of the ligand bound to Lp-PLA<sub>2</sub>.</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 2-Fluoro-5-{2-[(4<i>R</i>)-4-(4-methyl-1,1-dioxo-1λ<sup>6</sup>-thian-4-yl)-2-oxopyrrolidin-1-yl]ethoxy}benzonitrile (<b>(</b><i><b>R</b></i><b>)-23</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 7.36–7.32 (m, 1H), 7.32–7.26 (m, 2H), 4.19 (t, <i>J</i> = 5.3 Hz, 2H), 3.74 (dt, <i>J</i> = 14.6, 5.2 Hz, 1H), 3.68–3.57 (m, 2H), 3.49 (dd, <i>J</i> = 10.2, 7.4 Hz, 1H), 3.20–3.10 (m, 2H), 3.05–2.95 (m, 2H), 2.56 (app quin, <i>J</i> = 8.6 Hz, 1H), 2.42 (dd, <i>J</i> = 17.0, 9.1 Hz, 1H), 2.35 (dd, <i>J</i> = 17.0, 9.1 Hz, 1H), 2.04–1.94 (m, 2H), 1.89–1.81 (m, 2H), 1.04 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD): δ 175.3, 157.8 (d, <i>J</i> = 250.1 Hz), 154.9 (d, <i>J</i> = 2.2 Hz), 122.1 (d, <i>J</i> = 8.1 Hz), 117.7, 117.1 (d, <i>J</i> = 22.0 Hz), 113.2, 100.9 (d, <i>J</i> = 16.9 Hz), 66.2, 48.8, 46.4, 41.8, 39.7, 32.9, 32.7, 32.2, 31.6, 17.3. LCMS (method 2): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 412, RT = 1.23 min. Purity >95%. HRMS (ESI-QTOF): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>S is 395.1435; found, 395.1430 (Δ = −1.09 ppm). <i>ee</i> > 99%.</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 4-Methylthiane-4-carbaldehyde (<b>27</b>)</h5><div class="NLM_p last">A stirred solution of thiane-4-carbaldehyde (0.90 g, 6.91 mmol) in THF (23 mL) was cooled in an ice–water bath, and then <i>t</i>-BuOK (0.93 g, 8.30 mmol) was added. After 10 min, MeI (0.67 mL, 10.8 mmol) was added neat. The mixture was stirred with cooling for 2 h. The reaction was quenched with sat. aquoeus NH<sub>4</sub>Cl, and the product was extracted with DCM (×3). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo to yield 4-methylthiane-4-carbaldehyde (<b>27</b>) as a colorless oil (0.94 g, 94%). The product was used in the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.42 (s, 1H), 2.72–2.53 (m, 4H), 2.25–2.15 (m, 2H), 1.72–1.62 (m, 2H), 1.07 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 205.2, 45.5, 33.5, 24.6, 22.2. Purity 90%. HRMS (ESI-QTOF): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>7</sub>H<sub>12</sub>OS is 145.0680; found, 145.0680 (Δ = 0.26 ppm).</div></div><div id="sec4_2_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Ethyl (2<i>E</i>)-3-(4-Methylthian-4-yl)prop-2-enoate (<b>28</b>)</h5><div class="NLM_p last">A stirred solution of <i>t</i>-BuOK (1.32 g, 11.7 mmol) in THF (20 mL) was cooled in an ice–water bath, and then triethyl phosphonoacetate (2.03 mL, 12.3 mmol) was added. After 30 min, 4-methylthiane-4-carbaldehyde (<b>27</b>) (0.94, g, 5.87 mmol, 90% pure) was added in THF (9 mL). The reaction was stirred for 3 h and then quenched with sat. aqueous NH<sub>4</sub>Cl. After further dilution with water, the product was extracted with DCM (×3). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo. The product was purified by flash chromatography (gradient elution with 0–20% EtOAc/petrol) to yield ethyl (2<i>E</i>)-3-(4-methylthian-4-yl)prop-2-enoate (<b>28</b>) as a colorless oil (1.2 g, 96%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.90 (d, <i>J</i> = 16.2 Hz, 1H), 5.79 (d, <i>J</i> = 16.2 Hz, 1H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 2.70–2.59 (m, 4H), 1.93 (ddd, <i>J</i> = 13.9, 7.1, 3.7 Hz, 2H), 1.74 (ddd, <i>J</i> = 13.9, 8.2, 3.9 Hz, 2H), 1.32 (t, <i>J</i> = 7.1 Hz, 3H), 1.09 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 166.9, 156.5, 119.2, 60.4, 37.8, 35.9, 26.6, 24.2, 14.3. Purity 90%.</div></div><div id="sec4_2_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Ethyl 3-(4-Methylthian-4-yl)-4-nitrobutanoate (<b>(±)-29</b>)</h5><div class="NLM_p last">To a mixture of ethyl (2<i>E</i>)-3-(4-methylthian-4-yl)prop-2-enoate (<b>28</b>) (1.80 g, 8.40 mmol) and nitromethane (5.1 g, 84.0 mmol) was added 1,1,3,3-tetramethylguanidine (967 mg, 8.40 mmol). The reaction was heated at 100 °C (microwave) for 4 h and then left at ambient temperature overnight. The mixture was diluted with 2 M HCl, and the product was extracted EtOAc (×1). The organic layer was separated washed with water, dried with brine, and evaporated in vacuo. The crude product was purified by preparative TLC (10:1 = petrol/EtOAc) to yield ethyl 3-(4-methylthian-4-yl)-4-nitrobutanoate (<b>(±)-29</b>) (1.0 g, 43%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 4.56 (dd, <i>J</i> = 12.8, 4.4 Hz, 1H), 4.35 (dd, <i>J</i> = 13.2, 7.6 Hz, 1H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 3.67–3.77 (m, 1H), 2.78–2.68 (m, 3H), 2.61–2.53 (m, 2H), 2.30 (dd, <i>J</i> = 16.4, 8.4 Hz, 1H), 1.64–1.73 (m, 4H), 1.19–1.28 (m, 3H), 0.89 (s, 3H). Purity >90%.</div></div><div id="sec4_2_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 4-(4-Methylthian-4-yl)pyrrolidin-2-one (<b>(±)-30</b>)</h5><div class="NLM_p last">A mixture of ethyl 3-(4-methylthian-4-yl)-4-nitrobutanoate (<b>(±)-29</b>) (216 mg, 0.79 mmol) in MeOH (16 mL) was cooled in an ice/water/salt bath, and then NiCl<sub>2</sub>·6H<sub>2</sub>O (205 mg, 0.86 mmol) was added. NaBH<sub>4</sub> (89 mg, 2.4 mmol) was carefully added in portions. The reaction was stirred for a further 1.5 h with cooling and was then allowed to warm to ambient temperature. The reaction was quenched with 2 M HCl and stirred for a further 1 h. MeOH was removed in vacuo, and the product was extracted with EtOAc (×3). The combined organic layers were washed with water and then brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo. The product was purified by flash chromatography (gradient elution with MeOH/EtOAc) to yield 4-(4-methylthian-4-yl)pyrrolidin-2-one (<b>(±)-30</b>) as a colorless solid (102 mg, 65%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.50 (br s, 1H), 3.32 (t, <i>J</i> = 9.1 Hz, 1H), 3.23 (t, <i>J</i> = 9.1 Hz, 1H), 2.83–2.70 (m, 2H), 2.54–2.43 (m, 3H), 2.21 (d, <i>J</i> = 9.7 Hz, 2H), 1.66–1.57 (m, 4H), 0.91 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 177.9, 44.5, 42.4, 36.5, 35.9, 33.2, 30.8, 23.5, 23.4, 19.3. Purity >95%. HRMS (ESI-QTOF): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>10</sub>H<sub>17</sub>NOS, 200.1104; found, 200.1105 (Δ = 0.68 ppm).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01427">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01427" class="ext-link">10.1021/acs.jmedchem.6b01427</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Biophysical assay protocols, supplementary tables, crystallographic details, in vitro assay details, PK details, synthetic schemes, experimental procedures, and characterization of organic molecules (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_001.pdf">jm6b01427_si_001.pdf (2.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_002.csv">jm6b01427_si_002.csv (2.27 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates for the Lp-PLA<sub>2</sub> complexes with compounds <b>2</b>–<b>5</b>, <b>13</b>, <b>(<i><b>S</b></i>)-15</b>, <b>(</b><i><b>R</b></i><b>)-15</b>, <b>(±)-18</b>, and <b>(</b><i><b>S</b></i><b>)-23</b> have been deposited in the Protein Data Bank (PDB) under accession codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAN">5JAN</a> (<b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAH">5JAH</a> (<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ2">5LZ2</a> (<b>4</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYY">5LYY</a> (<b>5</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ4">5LZ4</a> (<b>13</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ5">5LZ5</a> (<b>(</b><i><b>S</b></i><b>)-15</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ7">5LZ7</a> (<b>(</b><i><b>R</b></i><b>)-15</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ8">5LZ8</a> (<b>(±)-18</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ9">5LZ9</a> (<b>(</b><i><b>S</b></i><b>)-23</b>). We will release the atomic coordinates in experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01427" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alison J.-A. Woolford</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8acbe6e3f9e5e4a4dde5e5e6ece5f8eecaebf9fef2a4e9e5e7"><span class="__cf_email__" data-cfemail="ebaa8782988485c5bc8484878d84998fab8a989f93c5888486">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vipulkumar K. Patel</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cc9aa5bcb9a0e287e29cadb8a9a08c8b9f87e2afa3a1"><span class="__cf_email__" data-cfemail="5d0b342d28317316730d3c2938311d1a0e16733e3230">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip J. Day</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Véronique Bénéton</span> - <span class="hlFld-Affiliation affiliation">Centre
de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerio Berdini</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph E. Coyle</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yann Dudit</span> - <span class="hlFld-Affiliation affiliation">Centre
de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Grondin</span> - <span class="hlFld-Affiliation affiliation">Centre
de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Huet</span> - <span class="hlFld-Affiliation affiliation">Centre
de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lydia Y. W. Lee</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric S. Manas</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel L. McMenamin</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher W. Murray</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lee W. Page</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florent Potvain</span> - <span class="hlFld-Affiliation affiliation">Centre
de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharna J. Rich</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingxia Sang</span> - <span class="hlFld-Affiliation affiliation">Neurodegeneration
DPU, GlaxoSmithKline, 898 Halei Road, Zhangjiang Hi-Tech
Park, Pudong, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Don O. Somers</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lionel Trottet</span> - <span class="hlFld-Affiliation affiliation">Centre
de Recherches Francois Hyafil, GlaxoSmithKline, 25−27 Avenue du Québec, Les Ulis, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zehong Wan</span> - <span class="hlFld-Affiliation affiliation">Neurodegeneration
DPU, GlaxoSmithKline, 898 Halei Road, Zhangjiang Hi-Tech
Park, Pudong, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaomin Zhang</span> - <span class="hlFld-Affiliation affiliation">Neurodegeneration
DPU, GlaxoSmithKline, 898 Halei Road, Zhangjiang Hi-Tech
Park, Pudong, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.J.-A.W. and P.J.D. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2997-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We express our appreciation to Shenaz Bunally, Anne Cleasby, Marie-Hélène Fouchet, David Rees, Jeff Yon, Musundi B. Wabuyele, and Stuart Whibley for providing their support during the project and our thanks to Ben Cons and Jeff St. Denis for useful comments on the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> Abbreviations Used</h2><tr><td class="NLM_term">HAC</td><td class="NLM_def"><p class="first last">heavy atom count</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">% I</td><td class="NLM_def"><p class="first last">percent inhibition of signal relative to the solvent-only control</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight in g mol<sup>–1</sup></p></td></tr><tr><td class="NLM_term">petrol</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Six, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, E. A.</span><span> </span><span class="NLM_article-title">The expanding superfamily of phospholipase A(2) enzymes: classification and characterization</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1488</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1016/S1388-1981(00)00105-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS1388-1981%2800%2900105-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=11080672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlGisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1488&publication_year=2000&pages=1-19&author=D.+A.+Sixauthor=E.+A.+Dennis&title=The+expanding+superfamily+of+phospholipase+A%282%29+enzymes%3A+classification+and+characterization&doi=10.1016%2FS1388-1981%2800%2900105-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The expanding superfamily of phospholipase A2 enzymes: classification and characterization</span></div><div class="casAuthors">Six, D. A.; Dennis, E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1488</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review and discussion with 189 refs.  The phospholipase A2 (PLA2) superfamily consists of a broad range of enzymes defined by their ability to catalyze the hydrolysis of the middle (sn-2) ester bond of substrate phospholipids.  The hydrolysis products of this reaction, free fatty acid and lysophospholipid, have many important downstream roles, and are derived from the activity of a diverse and growing superfamily of PLA2 enzymes.  This review updates the classification of the various PLA2's now described in the literature.  Four criteria have been employed to classify these proteins into one of the 11 groups (I-XI) of PLA2's.  First, the enzyme must catalyze the hydrolysis of the sn-2 ester bond of a natural phospholipid substrate, such as long fatty acid chain phospholipids, platelet activating factor, or short fatty acid chain oxidized phospholipids.  Second, the complete amino acid sequence of the mature protein must be known.  Third, each PLA2 group should include all of those enzymes that have readily identifiable sequence homol.  If more than one homologous PLA2 gene exists within a species, then each paralog should be assigned a subgroup letter, as in the case of group IVA, IVB, and IVC PLA2.  Homologs from different species should be classified within the same subgroup wherever such assignments are possible as is the case with zebra fish and human group IVA PLA2 orthologs.  The current classification scheme does allow for historical exceptions of the highly homologous group I, II, V, and X PLA2's.  Fourth, catalytically active splice variants of the same gene are classified as the same group and subgroup, but distinguished using Arabic nos., such as for group VIA-1 PLA2 and VIA-2 PLA2's.  These 4 criteria have led to the expansion or realignment of groups VI, VII and VIII, as well as the addn. of group XI PLA2 from plants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8DKWoAZlTrVg90H21EOLACvtfcHk0lhAVHwTbq13TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlGisbo%253D&md5=70fc2db5490a692b8b961fa40e543d6f</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2800%2900105-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252800%252900105-0%26sid%3Dliteratum%253Aachs%26aulast%3DSix%26aufirst%3DD.%2BA.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26atitle%3DThe%2520expanding%2520superfamily%2520of%2520phospholipase%2520A%25282%2529%2520enzymes%253A%2520classification%2520and%2520characterization%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2000%26volume%3D1488%26spage%3D1%26epage%3D19%26doi%3D10.1016%2FS1388-1981%2800%2900105-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schaloske, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, E. A.</span><span> </span><span class="NLM_article-title">The phospholipase A2 superfamily and its group numbering system</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1761</span><span class="NLM_x">, </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1259</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2006.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bbalip.2006.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=16973413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CisLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1761&publication_year=2006&pages=1246-1259&author=R.+H.+Schaloskeauthor=E.+A.+Dennis&title=The+phospholipase+A2+superfamily+and+its+group+numbering+system&doi=10.1016%2Fj.bbalip.2006.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The phospholipase A2 superfamily and its group numbering system</span></div><div class="casAuthors">Schaloske, Ralph H.; Dennis, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1761</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1246-1259</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The superfamily of phospholipase A2 (PLA2) enzymes currently consists of 15 groups and many subgroups and includes 5 distinct types of enzymes, namely the secretory PLA2s (sPLA2), the cytosolic PLA2s (cPLA2), the Ca2+-independent PLA2s (iPLA2), the platelet-activating factor acetylhydrolases (PAF-AH), and the lysosomal PLA2s.  In 1994, the authors established the systematic group numbering system for these enzymes.  Since then, the PLA2 superfamily has grown continuously and over the intervening years has required several updates of this group numbering system.  Since the last update, a no. of new PLA2s have been discovered and are now included.  Addnl., tools for the investigation of PLA2s and approaches for distinguishing between the different groups are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zJ1-ln1MRbVg90H21EOLACvtfcHk0lhAVHwTbq13TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CisLvM&md5=0c7b3bfc7e061cfb62b1ba5659c2e0b9</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2006.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2006.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DSchaloske%26aufirst%3DR.%2BH.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26atitle%3DThe%2520phospholipase%2520A2%2520superfamily%2520and%2520its%2520group%2520numbering%2520system%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2006%26volume%3D1761%26spage%3D1246%26epage%3D1259%26doi%3D10.1016%2Fj.bbalip.2006.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Stafforini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, S. M.</span><span> </span><span class="NLM_article-title">Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">4215</span><span class="NLM_x">–</span> <span class="NLM_lpage">4222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=4215-4222&author=D.+M.+Stafforiniauthor=T.+M.+McIntyreauthor=M.+E.+Carterauthor=S.+M.+Prescott&title=Human+plasma+platelet-activating+factor+acetylhydrolase.+Association+with+lipoprotein+particles+and+role+in+the+degradation+of+platelet-activating+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStafforini%26aufirst%3DD.%2BM.%26aulast%3DMcIntyre%26aufirst%3DT.%2BM.%26aulast%3DCarter%26aufirst%3DM.%2BE.%26aulast%3DPrescott%26aufirst%3DS.%2BM.%26atitle%3DHuman%2520plasma%2520platelet-activating%2520factor%2520acetylhydrolase.%2520Association%2520with%2520lipoprotein%2520particles%2520and%2520role%2520in%2520the%2520degradation%2520of%2520platelet-activating%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D4215%26epage%3D4222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stremler, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafforini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, T. M.</span><span> </span><span class="NLM_article-title">An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">5331</span><span class="NLM_x">–</span> <span class="NLM_lpage">5334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=5331-5334&author=K.+E.+Stremlerauthor=D.+M.+Stafforiniauthor=S.+M.+Prescottauthor=G.+A.+Zimmermanauthor=T.+M.+McIntyre&title=An+oxidized+derivative+of+phosphatidylcholine+is+a+substrate+for+the+platelet-activating+factor+acetylhydrolase+from+human+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStremler%26aufirst%3DK.%2BE.%26aulast%3DStafforini%26aufirst%3DD.%2BM.%26aulast%3DPrescott%26aufirst%3DS.%2BM.%26aulast%3DZimmerman%26aufirst%3DG.%2BA.%26aulast%3DMcIntyre%26aufirst%3DT.%2BM.%26atitle%3DAn%2520oxidized%2520derivative%2520of%2520phosphatidylcholine%2520is%2520a%2520substrate%2520for%2520the%2520platelet-activating%2520factor%2520acetylhydrolase%2520from%2520human%2520plasma%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D5331%26epage%3D5334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stremler, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafforini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, T. M.</span><span> </span><span class="NLM_article-title">Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">11095</span><span class="NLM_x">–</span> <span class="NLM_lpage">11103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=11095-11103&author=K.+E.+Stremlerauthor=D.+M.+Stafforiniauthor=S.+M.+Prescottauthor=T.+M.+McIntyre&title=Human+plasma+platelet-activating+factor+acetylhydrolase.+Oxidatively+fragmented+phospholipids+as+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStremler%26aufirst%3DK.%2BE.%26aulast%3DStafforini%26aufirst%3DD.%2BM.%26aulast%3DPrescott%26aufirst%3DS.%2BM.%26aulast%3DMcIntyre%26aufirst%3DT.%2BM.%26atitle%3DHuman%2520plasma%2520platelet-activating%2520factor%2520acetylhydrolase.%2520Oxidatively%2520fragmented%2520phospholipids%2520as%2520substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D11095%26epage%3D11103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">MacPhee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moores, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leake, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milliner, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckling, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span> </span><span class="NLM_article-title">Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x"> (</span><span class="NLM_issue">Pt 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1042/0264-6021:3380479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1042%2F0264-6021%3A3380479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1999&pages=479-487&issue=Pt+2&author=C.+H.+MacPheeauthor=K.+E.+Mooresauthor=H.+F.+Boydauthor=D.+Dhanakauthor=R.+J.+Ifeauthor=C.+A.+Leachauthor=D.+S.+Leakeauthor=K.+J.+Millinerauthor=R.+A.+Pattersonauthor=K.+E.+Sucklingauthor=D.+G.+Tewauthor=D.+M.+Hickey&title=Lipoprotein-associated+phospholipase+A2%2C+platelet-activating+factor+acetylhydrolase%2C+generates+two+bioactive+products+during+the+oxidation+of+low-density+lipoprotein%3A+use+of+a+novel+inhibitor&doi=10.1042%2F0264-6021%3A3380479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1042%2F0264-6021%3A3380479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252F0264-6021%253A3380479%26sid%3Dliteratum%253Aachs%26aulast%3DMacPhee%26aufirst%3DC.%2BH.%26aulast%3DMoores%26aufirst%3DK.%2BE.%26aulast%3DBoyd%26aufirst%3DH.%2BF.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26aulast%3DLeake%26aufirst%3DD.%2BS.%26aulast%3DMilliner%26aufirst%3DK.%2BJ.%26aulast%3DPatterson%26aufirst%3DR.%2BA.%26aulast%3DSuckling%26aufirst%3DK.%2BE.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26atitle%3DLipoprotein-associated%2520phospholipase%2520A2%252C%2520platelet-activating%2520factor%2520acetylhydrolase%252C%2520generates%2520two%2520bioactive%2520products%2520during%2520the%2520oxidation%2520of%2520low-density%2520lipoprotein%253A%2520use%2520of%2520a%2520novel%2520inhibitor%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D338%26issue%3DPt%25202%26spage%3D479%26epage%3D487%26doi%3D10.1042%2F0264-6021%3A3380479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orfei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Angelantonio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptoge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criqui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danesh, J.</span><span> </span><span class="NLM_article-title">Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">1536</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)60319-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS0140-6736%2810%2960319-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=1536-1544&author=A.+Thompsonauthor=P.+Gaoauthor=L.+Orfeiauthor=S.+Watsonauthor=E.+Di+Angelantonioauthor=S.+Kaptogeauthor=C.+Ballantyneauthor=C.+P.+Cannonauthor=M.+Criquiauthor=M.+Cushmanauthor=A.+Hofmanauthor=C.+Packardauthor=S.+G.+Thompsonauthor=R.+Collinsauthor=J.+Danesh&title=Lipoprotein-associated+phospholipase+A%282%29+and+risk+of+coronary+disease%2C+stroke%2C+and+mortality%3A+collaborative+analysis+of+32+prospective+studies&doi=10.1016%2FS0140-6736%2810%2960319-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2960319-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252960319-4%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DOrfei%26aufirst%3DL.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DDi%2BAngelantonio%26aufirst%3DE.%26aulast%3DKaptoge%26aufirst%3DS.%26aulast%3DBallantyne%26aufirst%3DC.%26aulast%3DCannon%26aufirst%3DC.%2BP.%26aulast%3DCriqui%26aufirst%3DM.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DHofman%26aufirst%3DA.%26aulast%3DPackard%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DS.%2BG.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DDanesh%26aufirst%3DJ.%26atitle%3DLipoprotein-associated%2520phospholipase%2520A%25282%2529%2520and%2520risk%2520of%2520coronary%2520disease%252C%2520stroke%252C%2520and%2520mortality%253A%2520collaborative%2520analysis%2520of%252032%2520prospective%2520studies%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D1536%26epage%3D1544%26doi%3D10.1016%2FS0140-6736%2810%2960319-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fitzpatrick, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irizarry, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koro, C.</span><span> </span><span class="NLM_article-title">Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.atherosclerosis.2014.04.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2014&pages=384-391&author=A.+L.+Fitzpatrickauthor=M.+C.+Irizarryauthor=M.+Cushmanauthor=N.+S.+Jennyauthor=G.+C.+Chiauthor=C.+Koro&title=Lipoprotein-associated+phospholipase+A2+and+risk+of+dementia+in+the+Cardiovascular+Health+Study&doi=10.1016%2Fj.atherosclerosis.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DA.%2BL.%26aulast%3DIrizarry%26aufirst%3DM.%2BC.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DJenny%26aufirst%3DN.%2BS.%26aulast%3DChi%26aufirst%3DG.%2BC.%26aulast%3DKoro%26aufirst%3DC.%26atitle%3DLipoprotein-associated%2520phospholipase%2520A2%2520and%2520risk%2520of%2520dementia%2520in%2520the%2520Cardiovascular%2520Health%2520Study%26jtitle%3DAtherosclerosis%26date%3D2014%26volume%3D235%26spage%3D384%26epage%3D391%26doi%3D10.1016%2Fj.atherosclerosis.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Staurenghi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurzelmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span> </span><span class="NLM_article-title">Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study</span> <span class="citation_source-journal">Ophthalmology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1016/j.ophtha.2014.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.ophtha.2014.12.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2015&pages=990-996&author=G.+Staurenghiauthor=L.+Yeauthor=M.+H.+Mageeauthor=R.+P.+Danisauthor=J.+Wurzelmannauthor=P.+Adamsonauthor=M.+M.+McLaughlin&title=Darapladib%2C+a+lipoprotein-associated+phospholipase+A2+inhibitor%2C+in+diabetic+macular+edema%3A+a+3-month+placebo-controlled+study&doi=10.1016%2Fj.ophtha.2014.12.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ophtha.2014.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ophtha.2014.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DStaurenghi%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DMagee%26aufirst%3DM.%2BH.%26aulast%3DDanis%26aufirst%3DR.%2BP.%26aulast%3DWurzelmann%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DP.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26atitle%3DDarapladib%252C%2520a%2520lipoprotein-associated%2520phospholipase%2520A2%2520inhibitor%252C%2520in%2520diabetic%2520macular%2520edema%253A%2520a%25203-month%2520placebo-controlled%2520study%26jtitle%3DOphthalmology%26date%3D2015%26volume%3D122%26spage%3D990%26epage%3D996%26doi%3D10.1016%2Fj.ophtha.2014.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vainio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpindi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohonen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaegh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alanen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iljin, K.</span><span> </span><span class="NLM_article-title">Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2010.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.ajpath.2010.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=21281786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVOlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2011&pages=525-536&author=P.+Vainioauthor=S.+Guptaauthor=K.+Ketolaauthor=T.+Mirttiauthor=J.+P.+Mpindiauthor=P.+Kohonenauthor=V.+Feyauthor=M.+Peralaauthor=F.+Smitauthor=G.+Verhaeghauthor=J.+Schalkenauthor=K.+A.+Alanenauthor=O.+Kallioniemiauthor=K.+Iljin&title=Arachidonic+acid+pathway+members+PLA2G7%2C+HPGD%2C+EPHX2%2C+and+CYP4F8+identified+as+putative+novel+therapeutic+targets+in+prostate+cancer&doi=10.1016%2Fj.ajpath.2010.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer</span></div><div class="casAuthors">Vainio, Paula; Gupta, Santosh; Ketola, Kirsi; Mirtti, Tuomas; Mpindi, John-Patrick; Kohonen, Pekka; Fey, Vidal; Perala, Merja; Smit, Frank; Verhaegh, Gerald; Schalken, Jack; Alanen, Kalle A.; Kallioniemi, Olli; Iljin, Kristiina</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-536</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The arachidonic acid and prostaglandin pathway has been implicated in prostate carcinogenesis, but comprehensive studies of the individual members in this key pathway are lacking.  Here, we first conducted a systematic bioinformatic study of the expression of 36 arachidonic acid pathway genes across 9783 human tissue samples.  The results showed that the PLA2G7, HPGD, EPHX2, and CYP4F8 genes are highly expressed in prostate cancer.  Functional studies using RNA interference in prostate cancer cells indicated that all four genes are also essential for cell growth and survival.  Clin. validation confirmed high PLA2G7 expression, esp. in ERG oncogene-pos. prostate cancers, and its silencing sensitized ERG-pos. prostate cancer cells to oxidative stress.  HPGD was highly expressed in androgen receptor (AR)-overexpressing advanced tumors, as well as in metastatic prostate cancers.  EPHX2 mRNA correlated with AR in primary prostate cancers, and its inhibition in vitro reduced AR signaling and potentiated the effect of antiandrogen flutamide in cultured prostate cancer cells.  In summary, we identified four novel putative therapeutic targets with biomarker potential for different subtypes of prostate cancer.  In addn., our results indicate that inhibition of these enzymes may be particularly powerful when combined with other treatments, such as androgen deprivation or induction of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreGcJNZN3L4LVg90H21EOLACvtfcHk0ljWxkbAVn-dkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVOlsbs%253D&md5=151d70302659b8efe677b1ee7a912635</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2010.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2010.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DVainio%26aufirst%3DP.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DKetola%26aufirst%3DK.%26aulast%3DMirtti%26aufirst%3DT.%26aulast%3DMpindi%26aufirst%3DJ.%2BP.%26aulast%3DKohonen%26aufirst%3DP.%26aulast%3DFey%26aufirst%3DV.%26aulast%3DPerala%26aufirst%3DM.%26aulast%3DSmit%26aufirst%3DF.%26aulast%3DVerhaegh%26aufirst%3DG.%26aulast%3DSchalken%26aufirst%3DJ.%26aulast%3DAlanen%26aufirst%3DK.%2BA.%26aulast%3DKallioniemi%26aufirst%3DO.%26aulast%3DIljin%26aufirst%3DK.%26atitle%3DArachidonic%2520acid%2520pathway%2520members%2520PLA2G7%252C%2520HPGD%252C%2520EPHX2%252C%2520and%2520CYP4F8%2520identified%2520as%2520putative%2520novel%2520therapeutic%2520targets%2520in%2520prostate%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D178%26spage%3D525%26epage%3D536%26doi%3D10.1016%2Fj.ajpath.2010.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vainio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtinen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seppanen-Laakso, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virtanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rannikko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oresic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iljin, K.</span><span> </span><span class="NLM_article-title">Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span><span class="refDoi"> DOI: 10.18632/oncotarget.397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.18632%2Foncotarget.397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1176-1190&author=P.+Vainioauthor=L.+Lehtinenauthor=T.+Mirttiauthor=M.+Hilvoauthor=T.+Seppanen-Laaksoauthor=J.+Virtanenauthor=A.+Sankilaauthor=S.+Nordlingauthor=J.+Lundinauthor=A.+Rannikkoauthor=M.+Oresicauthor=O.+Kallioniemiauthor=K.+Iljin&title=Phospholipase+PLA2G7%2C+associated+with+aggressive+prostate+cancer%2C+promotes+prostate+cancer+cell+migration+and+invasion+and+is+inhibited+by+statins&doi=10.18632%2Foncotarget.397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.397%26sid%3Dliteratum%253Aachs%26aulast%3DVainio%26aufirst%3DP.%26aulast%3DLehtinen%26aufirst%3DL.%26aulast%3DMirtti%26aufirst%3DT.%26aulast%3DHilvo%26aufirst%3DM.%26aulast%3DSeppanen-Laakso%26aufirst%3DT.%26aulast%3DVirtanen%26aufirst%3DJ.%26aulast%3DSankila%26aufirst%3DA.%26aulast%3DNordling%26aufirst%3DS.%26aulast%3DLundin%26aufirst%3DJ.%26aulast%3DRannikko%26aufirst%3DA.%26aulast%3DOresic%26aufirst%3DM.%26aulast%3DKallioniemi%26aufirst%3DO.%26aulast%3DIljin%26aufirst%3DK.%26atitle%3DPhospholipase%2520PLA2G7%252C%2520associated%2520with%2520aggressive%2520prostate%2520cancer%252C%2520promotes%2520prostate%2520cancer%2520cell%2520migration%2520and%2520invasion%2520and%2520is%2520inhibited%2520by%2520statins%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D1176%26epage%3D1190%26doi%3D10.18632%2Foncotarget.397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bertilsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessem, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viset, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribbestad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgunset, J.</span><span> </span><span class="NLM_article-title">Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3261</span><span class="NLM_x">–</span> <span class="NLM_lpage">3269</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-2929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1158%2F1078-0432.CCR-11-2929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=22510345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1Oltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=3261-3269&author=H.+Bertilssonauthor=M.+B.+Tessemauthor=A.+Flatbergauthor=T.+Visetauthor=I.+Gribbestadauthor=A.+Angelsenauthor=J.+Halgunset&title=Changes+in+gene+transcription+underlying+the+aberrant+citrate+and+choline+metabolism+in+human+prostate+cancer+samples&doi=10.1158%2F1078-0432.CCR-11-2929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in Gene Transcription Underlying the Aberrant Citrate and Choline Metabolism in Human Prostate Cancer Samples</span></div><div class="casAuthors">Bertilsson, Helena; Tessem, May-Britt; Flatberg, Arnar; Viset, Trond; Gribbestad, Ingrid; Angelsen, Anders; Halgunset, Jostein</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3261-3269</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Low concns. of citrate and high concns. of choline-contg. compds. (ChoCC) are metabolic characteristics obsd. by magnetic resonance spectroscopy of prostate cancer tissue.  The objective was to investigate the gene expression changes underlying these metabolic aberrations to find regulatory genes with potential for targeted therapies.  Exptl. design: Fresh frozen samples (n = 133) from 41 patients undergoing radical prostatectomy were included.  Histopathol. evaluation was carried out for each sample before a metabolic profile was obtained with high-resoln. magic angle spinning (HR-MAS) spectroscopy.  Following the HR-MAS, RNA was extd. from the same sample and quality controlled before carrying out microarray gene expression profiling.  A partial least square statistical model was used to integrate the data sets to identify genes whose expression show significant covariance with citrate and ChoCC levels.  Results: Samples were classified as benign, n = 35; cancer of low grade (Gleason score 6), n = 24; intermediate grade (Gleason score 7), n = 41; or high grade (Gleason score ≥8), n = 33.  RNA quality was high with a mean RNA Integrity No. score of 9.1 (SD 1.2).  Gene products predicting significantly a reduced citrate level were acetyl citrate lyase (ACLY, P = 0.003) and m-aconitase (ACON, P < 0.001).  The two genes whose expression most closely accompanied the increase in ChoCC were those of phospholipase A2 group VII (PLA2G7, P < 0.001) and choline kinase α (CHKA, P = 0.002).  Conclusions: By integrating histol., transcriptomic, and metabolic data, our study has contributed to an expanded understanding of the mechanisms underlying aberrant citrate and ChoCC levels in prostate cancer.  Clin Cancer Res; 18(12); 3261-9. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWms-kGf7vGrVg90H21EOLACvtfcHk0lgAYOs4r_wZuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1Oltb8%253D&md5=9e6b8df07ca73835ece816dde841fba6</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2929%26sid%3Dliteratum%253Aachs%26aulast%3DBertilsson%26aufirst%3DH.%26aulast%3DTessem%26aufirst%3DM.%2BB.%26aulast%3DFlatberg%26aufirst%3DA.%26aulast%3DViset%26aufirst%3DT.%26aulast%3DGribbestad%26aufirst%3DI.%26aulast%3DAngelsen%26aufirst%3DA.%26aulast%3DHalgunset%26aufirst%3DJ.%26atitle%3DChanges%2520in%2520gene%2520transcription%2520underlying%2520the%2520aberrant%2520citrate%2520and%2520choline%2520metabolism%2520in%2520human%2520prostate%2520cancer%2520samples%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D3261%26epage%3D3269%26doi%3D10.1158%2F1078-0432.CCR-11-2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Serruys, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Garcia, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buszman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botker, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Birgelen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambanini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastik, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Es, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Steen, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijns, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Integrated, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaging Study, I.</span><span> </span><span class="NLM_article-title">Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.108.771899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1161%2FCIRCULATIONAHA.108.771899" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1172-1182&author=P.+W.+Serruysauthor=H.+M.+Garcia-Garciaauthor=P.+Buszmanauthor=P.+Erneauthor=S.+Verheyeauthor=M.+Aschermannauthor=H.+Duckersauthor=O.+Bleieauthor=D.+Dudekauthor=H.+E.+Botkerauthor=C.+von+Birgelenauthor=D.+D%E2%80%99Amicoauthor=T.+Hutchinsonauthor=A.+Zambaniniauthor=F.+Mastikauthor=G.+A.+van+Esauthor=A.+F.+van+der+Steenauthor=D.+G.+Vinceauthor=P.+Ganzauthor=C.+W.+Hammauthor=W.+Wijnsauthor=A.+Zalewskiauthor=B.+Integratedauthor=I.+Imaging+Study&title=Effects+of+the+direct+lipoprotein-associated+phospholipase+A%282%29+inhibitor+darapladib+on+human+coronary+atherosclerotic+plaque&doi=10.1161%2FCIRCULATIONAHA.108.771899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.108.771899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.108.771899%26sid%3Dliteratum%253Aachs%26aulast%3DSerruys%26aufirst%3DP.%2BW.%26aulast%3DGarcia-Garcia%26aufirst%3DH.%2BM.%26aulast%3DBuszman%26aufirst%3DP.%26aulast%3DErne%26aufirst%3DP.%26aulast%3DVerheye%26aufirst%3DS.%26aulast%3DAschermann%26aufirst%3DM.%26aulast%3DDuckers%26aufirst%3DH.%26aulast%3DBleie%26aufirst%3DO.%26aulast%3DDudek%26aufirst%3DD.%26aulast%3DBotker%26aufirst%3DH.%2BE.%26aulast%3Dvon%2BBirgelen%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DD.%26aulast%3DHutchinson%26aufirst%3DT.%26aulast%3DZambanini%26aufirst%3DA.%26aulast%3DMastik%26aufirst%3DF.%26aulast%3Dvan%2BEs%26aufirst%3DG.%2BA.%26aulast%3Dvan%2Bder%2BSteen%26aufirst%3DA.%2BF.%26aulast%3DVince%26aufirst%3DD.%2BG.%26aulast%3DGanz%26aufirst%3DP.%26aulast%3DHamm%26aufirst%3DC.%2BW.%26aulast%3DWijns%26aufirst%3DW.%26aulast%3DZalewski%26aufirst%3DA.%26aulast%3DIntegrated%26aufirst%3DB.%26aulast%3DImaging%2BStudy%26aufirst%3DI.%26atitle%3DEffects%2520of%2520the%2520direct%2520lipoprotein-associated%2520phospholipase%2520A%25282%2529%2520inhibitor%2520darapladib%2520on%2520human%2520coronary%2520atherosclerotic%2520plaque%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1172%26epage%3D1182%26doi%3D10.1161%2FCIRCULATIONAHA.108.771899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Stability Investigators:</p></div><span class="NLM_contrib-group">White, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Held, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budaj, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steg, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardissino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avezum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aylward, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbalan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalby, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danchin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denchev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elisaf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flather, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudev, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinfeld, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husted, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Sendon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, E. R.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pais, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhomenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos-Corrales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sereg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddique, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnaeve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sritara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swart, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viigimaa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinereanu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallentin, L.</span><span> </span><span class="NLM_article-title">Darapladib for preventing ischemic events in stable coronary heart disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1711</span><span class="refDoi"> DOI: 10.1056/NEJMoa1315878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1056%2FNEJMoa1315878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=24678955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVemsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=1702-1711&author=H.+D.+Whiteauthor=C.+Heldauthor=R.+Stewartauthor=E.+Tarkaauthor=R.+Brownauthor=R.+Y.+Daviesauthor=A.+Budajauthor=R.+A.+Harringtonauthor=P.+G.+Stegauthor=D.+Ardissinoauthor=P.+W.+Armstrongauthor=A.+Avezumauthor=P.+E.+Aylwardauthor=A.+Bryceauthor=H.+Chenauthor=M.+F.+Chenauthor=R.+Corbalanauthor=A.+J.+Dalbyauthor=N.+Danchinauthor=R.+J.+De+Winterauthor=S.+Denchevauthor=R.+Diazauthor=M.+Elisafauthor=M.+D.+Flatherauthor=A.+R.+Goudevauthor=C.+B.+Grangerauthor=L.+Grinfeldauthor=J.+S.+Hochmanauthor=S.+Hustedauthor=H.+S.+Kimauthor=W.+Koenigauthor=A.+Linhartauthor=E.+Lonnauthor=J.+Lopez-Sendonauthor=A.+J.+Manolisauthor=E.+R.+Mohlerauthor=J.+C.+Nicolauauthor=P.+Paisauthor=A.+Parkhomenkoauthor=T.+R.+Pedersenauthor=D.+Pellaauthor=M.+A.+Ramos-Corralesauthor=M.+Rudaauthor=M.+Seregauthor=S.+Siddiqueauthor=P.+Sinnaeveauthor=P.+Smithauthor=P.+Sritaraauthor=H.+P.+Swartauthor=R.+G.+Syauthor=T.+Teramotoauthor=H.+F.+Tseauthor=D.+Watsonauthor=W.+D.+Weaverauthor=R.+Weissauthor=M.+Viigimaaauthor=D.+Vinereanuauthor=J.+Zhuauthor=C.+P.+Cannonauthor=L.+Wallentin&title=Darapladib+for+preventing+ischemic+events+in+stable+coronary+heart+disease&doi=10.1056%2FNEJMoa1315878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Darapladib for preventing ischemic events in stable coronary heart disease</span></div><div class="casAuthors">White, Harvey D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1702-1711</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Elevated lipoprotein-assocd. phospholipase A2 activity promotes the development of vulnerable atherosclerotic plaques, and elevated plasma levels of this enzyme are assocd. with an increased risk of coronary events.  Darapladib is a selective oral inhibitor of lipoprotein-assocd. phospholipase A2.  Methods: In a double-blind trial, we randomly assigned 15,828 patients with stable coronary heart disease to receive either once-daily darapladib (at a dose of 160 mg) or placebo.  The primary end point was the time to cardiovascular death, myocardial infarction, or stroke.  Secondary end points included the components of the primary end point as well as major coronary events (death from coronary heart disease, myocardial infarction, or urgent coronary revascularization for myocardial ischemia) and total coronary events (death from coronary heart disease, myocardial infarction, hospitalization for unstable angina, or any coronary revascularization).  Results: During a median follow-up period of 3.7 years, the primary end point occurred in 769 of 7924 patients (9.7%) in the darapladib group and 819 of 7904 patients (10.4%) in the placebo group (hazard ratio in the darapladib group, 0.94; 95% confidence interval [CI], 0.85 to 1.03; P = 0.20).  There were also no significant between-group differences in the rates of the individual components of the primary end point or in all-cause mortality.  Darapladib, as compared with placebo, reduced the rate of major coronary events (9.3% vs. 10.3%; hazard ratio, 0.90; 95% CI, 0.82 to 1.00; P = 0.045) and total coronary events (14.6% vs. 16.1%; hazard ratio, 0.91; 95% CI, 0.84 to 0.98; P = 0.02).  Conclusions: In patients with stable coronary heart disease, darapladib did not significantly reduce the risk of the primary composite end point of cardiovascular death, myocardial infarction, or stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEBKCDjmul8rVg90H21EOLACvtfcHk0lgAQHX-hJEClw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVemsbo%253D&md5=b53dfaab74ff4e029a99bfe054bf4a95</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1315878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1315878%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DH.%2BD.%26aulast%3DHeld%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DR.%26aulast%3DTarka%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DR.%2BY.%26aulast%3DBudaj%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26aulast%3DSteg%26aufirst%3DP.%2BG.%26aulast%3DArdissino%26aufirst%3DD.%26aulast%3DArmstrong%26aufirst%3DP.%2BW.%26aulast%3DAvezum%26aufirst%3DA.%26aulast%3DAylward%26aufirst%3DP.%2BE.%26aulast%3DBryce%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DM.%2BF.%26aulast%3DCorbalan%26aufirst%3DR.%26aulast%3DDalby%26aufirst%3DA.%2BJ.%26aulast%3DDanchin%26aufirst%3DN.%26aulast%3DDe%2BWinter%26aufirst%3DR.%2BJ.%26aulast%3DDenchev%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DR.%26aulast%3DElisaf%26aufirst%3DM.%26aulast%3DFlather%26aufirst%3DM.%2BD.%26aulast%3DGoudev%26aufirst%3DA.%2BR.%26aulast%3DGranger%26aufirst%3DC.%2BB.%26aulast%3DGrinfeld%26aufirst%3DL.%26aulast%3DHochman%26aufirst%3DJ.%2BS.%26aulast%3DHusted%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKoenig%26aufirst%3DW.%26aulast%3DLinhart%26aufirst%3DA.%26aulast%3DLonn%26aufirst%3DE.%26aulast%3DLopez-Sendon%26aufirst%3DJ.%26aulast%3DManolis%26aufirst%3DA.%2BJ.%26aulast%3DMohler%26aufirst%3DE.%2BR.%26aulast%3DNicolau%26aufirst%3DJ.%2BC.%26aulast%3DPais%26aufirst%3DP.%26aulast%3DParkhomenko%26aufirst%3DA.%26aulast%3DPedersen%26aufirst%3DT.%2BR.%26aulast%3DPella%26aufirst%3DD.%26aulast%3DRamos-Corrales%26aufirst%3DM.%2BA.%26aulast%3DRuda%26aufirst%3DM.%26aulast%3DSereg%26aufirst%3DM.%26aulast%3DSiddique%26aufirst%3DS.%26aulast%3DSinnaeve%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DSritara%26aufirst%3DP.%26aulast%3DSwart%26aufirst%3DH.%2BP.%26aulast%3DSy%26aufirst%3DR.%2BG.%26aulast%3DTeramoto%26aufirst%3DT.%26aulast%3DTse%26aufirst%3DH.%2BF.%26aulast%3DWatson%26aufirst%3DD.%26aulast%3DWeaver%26aufirst%3DW.%2BD.%26aulast%3DWeiss%26aufirst%3DR.%26aulast%3DViigimaa%26aufirst%3DM.%26aulast%3DVinereanu%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DCannon%26aufirst%3DC.%2BP.%26aulast%3DWallentin%26aufirst%3DL.%26atitle%3DDarapladib%2520for%2520preventing%2520ischemic%2520events%2520in%2520stable%2520coronary%2520heart%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D1702%26epage%3D1711%26doi%3D10.1056%2FNEJMoa1315878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Maher-Edwards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De’Ath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, A.</span><span> </span><span class="NLM_article-title">A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia: Transl. Res. Clin. Interventions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.trci.2015.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.trci.2015.06.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=131-140&author=G.+Maher-Edwardsauthor=J.+De%E2%80%99Athauthor=C.+Barnettauthor=A.+Lavrovauthor=A.+Lockhart&title=A+24-week+study+to+evaluate+the+effect+of+rilapladib+on+cognition+and+cerebrospinal+fluid+biomarkers+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.trci.2015.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaher-Edwards%26aufirst%3DG.%26aulast%3DDe%25E2%2580%2599Ath%26aufirst%3DJ.%26aulast%3DBarnett%26aufirst%3DC.%26aulast%3DLavrov%26aufirst%3DA.%26aulast%3DLockhart%26aufirst%3DA.%26atitle%3DA%252024-week%2520study%2520to%2520evaluate%2520the%2520effect%2520of%2520rilapladib%2520on%2520cognition%2520and%2520cerebrospinal%2520fluid%2520biomarkers%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%253A%2520Transl.%2520Res.%2520Clin.%2520Interventions%26date%3D2015%26volume%3D1%26spage%3D131%26epage%3D140%26doi%3D10.1016%2Fj.trci.2015.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">Recombinant human Lp-PLA<sub>2</sub> Thio-PAF assay. This is the primary Lp-PLA<sub>2</sub> bioassay that was employed to measure inhibition in of Lp-PLA<sub>2</sub>. It is a fluorescence intensity assay using Thio-Paf. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Recombinant human Lp-PLA<sub>2</sub> human plasma Thio-PAF assay. It is a secondary assay (also using Thio-Paf) that measures the inhibition of Lp-PLA<sub>2</sub> in whole human plasma. This assay functions to assess nonspecific binding events of inhibitors in plasma and approximates the physiological environment of the enzyme. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Shaddinger, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roger, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macphee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baidoo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepore, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprecher, D. L.</span><span> </span><span class="NLM_article-title">Platelet aggregation unchanged by lipoprotein-associated phospholipase A(2) inhibition: results from an in vitro study and two randomized phase I trials</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83094</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1371%2Fjournal.pone.0083094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e83094&author=B.+C.+Shaddingerauthor=Y.+Xuauthor=J.+H.+Rogerauthor=C.+H.+Macpheeauthor=M.+Handelauthor=C.+A.+Baidooauthor=M.+Mageeauthor=J.+J.+Leporeauthor=D.+L.+Sprecher&title=Platelet+aggregation+unchanged+by+lipoprotein-associated+phospholipase+A%282%29+inhibition%3A+results+from+an+in+vitro+study+and+two+randomized+phase+I+trials&doi=10.1371%2Fjournal.pone.0083094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083094%26sid%3Dliteratum%253Aachs%26aulast%3DShaddinger%26aufirst%3DB.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DRoger%26aufirst%3DJ.%2BH.%26aulast%3DMacphee%26aufirst%3DC.%2BH.%26aulast%3DHandel%26aufirst%3DM.%26aulast%3DBaidoo%26aufirst%3DC.%2BA.%26aulast%3DMagee%26aufirst%3DM.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DSprecher%26aufirst%3DD.%2BL.%26atitle%3DPlatelet%2520aggregation%2520unchanged%2520by%2520lipoprotein-associated%2520phospholipase%2520A%25282%2529%2520inhibition%253A%2520results%2520from%2520an%2520in%2520vitro%2520study%2520and%2520two%2520randomized%2520phase%2520I%2520trials%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De83094%26doi%3D10.1371%2Fjournal.pone.0083094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of imidazo[1,2-a]pyrimidine derivatives as potent and orally bioavailable lipoprotein-associated phospholipase A2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8529</span><span class="NLM_x">–</span> <span class="NLM_lpage">8541</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8529-8541&author=X.+Chenauthor=W.+Xuauthor=K.+Wangauthor=M.+Moauthor=W.+Zhangauthor=L.+Duauthor=X.+Yuanauthor=Y.+Xuauthor=Y.+Wangauthor=J.+Shen&title=Discovery+of+a+novel+series+of+imidazo%5B1%2C2-a%5Dpyrimidine+derivatives+as+potent+and+orally+bioavailable+lipoprotein-associated+phospholipase+A2+inhibitors&doi=10.1021%2Facs.jmedchem.5b01024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01024%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DMo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520imidazo%255B1%252C2-a%255Dpyrimidine%2520derivatives%2520as%2520potent%2520and%2520orally%2520bioavailable%2520lipoprotein-associated%2520phospholipase%2520A2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8529%26epage%3D8541%26doi%3D10.1021%2Facs.jmedchem.5b01024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nagano, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speers, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Vega, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A<sub>2</sub></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2012.11.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=839-843&author=J.+M.+G.+Naganoauthor=K.-L.+Hsuauthor=L.+R.+Whitbyauthor=M.+J.+Niphakisauthor=A.+E.+Speersauthor=S.+J.+Brownauthor=T.+Spicerauthor=V.+Fernandez-Vegaauthor=J.+Fergusonauthor=P.+Hodderauthor=P.+Srinivasanauthor=T.+D.+Gonzalezauthor=H.+Rosenauthor=B.+J.+Bahnsonauthor=B.+F.+Cravatt&title=Selective+inhibitors+and+tailored+activity+probes+for+lipoprotein-associated+phospholipase+A2&doi=10.1016%2Fj.bmcl.2012.11.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.061%26sid%3Dliteratum%253Aachs%26aulast%3DNagano%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DHsu%26aufirst%3DK.-L.%26aulast%3DWhitby%26aufirst%3DL.%2BR.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DSpeers%26aufirst%3DA.%2BE.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DSpicer%26aufirst%3DT.%26aulast%3DFernandez-Vega%26aufirst%3DV.%26aulast%3DFerguson%26aufirst%3DJ.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DSrinivasan%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DT.%2BD.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DSelective%2520inhibitors%2520and%2520tailored%2520activity%2520probes%2520for%2520lipoprotein-associated%2520phospholipase%2520A2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D839%26epage%3D843%26doi%3D10.1016%2Fj.bmcl.2012.11.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, C. A.</span><span> </span><span class="NLM_article-title">Mechanism of inhibition of LDL phospholipase A2 by monocyclic-beta-lactams. Burst kinetics and the effect of stereochemistry</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">10087</span><span class="NLM_x">–</span> <span class="NLM_lpage">10093</span><span class="refDoi"> DOI: 10.1021/bi9801412</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9801412" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=10087-10093&author=D.+G.+Tewauthor=H.+F.+Boydauthor=S.+Ashmanauthor=C.+Theobaldauthor=C.+A.+Leach&title=Mechanism+of+inhibition+of+LDL+phospholipase+A2+by+monocyclic-beta-lactams.+Burst+kinetics+and+the+effect+of+stereochemistry&doi=10.1021%2Fbi9801412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fbi9801412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9801412%26sid%3Dliteratum%253Aachs%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DBoyd%26aufirst%3DH.%2BF.%26aulast%3DAshman%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DC.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26atitle%3DMechanism%2520of%2520inhibition%2520of%2520LDL%2520phospholipase%2520A2%2520by%2520monocyclic-beta-lactams.%2520Burst%2520kinetics%2520and%2520the%2520effect%2520of%2520stereochemistry%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D10087%26epage%3D10093%26doi%3D10.1021%2Fbi9801412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Jeong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. S.</span><span> </span><span class="NLM_article-title">(<i>E</i>)-Phenyl- and -heteroaryl-substituted <i>O</i>-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.11.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2004.11.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1525-1527&author=T.+S.+Jeongauthor=M.+J.+Kimauthor=H.+Yuauthor=K.+S.+Kimauthor=J.+K.+Choiauthor=S.+S.+Kimauthor=W.+S.+Lee&title=%28E%29-Phenyl-+and+-heteroaryl-substituted+O-benzoyl-%28or+acyl%29oximes+as+lipoprotein-associated+phospholipase+A2+inhibitors&doi=10.1016%2Fj.bmcl.2004.11.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.11.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.11.063%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DT.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3D%2528E%2529-Phenyl-%2520and%2520-heteroaryl-substituted%2520O-benzoyl-%2528or%2520acyl%2529oximes%2520as%2520lipoprotein-associated%2520phospholipase%2520A2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1525%26epage%3D1527%26doi%3D10.1016%2Fj.bmcl.2004.11.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Jeong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. S.</span><span> </span><span class="NLM_article-title">Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde <i>O</i>-heterocycle-4-carbonyloxime</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5576</span><span class="NLM_x">–</span> <span class="NLM_lpage">5579</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2006.08.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5576-5579&author=H.+J.+Jeongauthor=Y.+D.+Parkauthor=H.+Y.+Parkauthor=I.+Y.+Jeongauthor=T.+S.+Jeongauthor=W.+S.+Lee&title=Potent+inhibitors+of+lipoprotein-associated+phospholipase+A%282%29%3A+benzaldehyde+O-heterocycle-4-carbonyloxime&doi=10.1016%2Fj.bmcl.2006.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DY.%2BD.%26aulast%3DPark%26aufirst%3DH.%2BY.%26aulast%3DJeong%26aufirst%3DI.%2BY.%26aulast%3DJeong%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3DPotent%2520inhibitors%2520of%2520lipoprotein-associated%2520phospholipase%2520A%25282%2529%253A%2520benzaldehyde%2520O-heterocycle-4-carbonyloxime%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5576%26epage%3D5579%26doi%3D10.1016%2Fj.bmcl.2006.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Lin, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amantea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cajica, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreder, K. R.</span><span> </span><span class="NLM_article-title">Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2011.12.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=868-871&author=E.+C.+Linauthor=Y.+Huauthor=C.+M.+Amanteaauthor=L.+M.+Phamauthor=J.+Cajicaauthor=E.+Okerbergauthor=H.+E.+Brownauthor=A.+Fraserauthor=L.+Duauthor=Y.+Kohnoauthor=J.+Ishiyamaauthor=J.+W.+Kozarichauthor=K.+R.+Shreder&title=Amides+of+xanthurenic+acid+as+zinc-dependent+inhibitors+of+Lp-PLA%282%29&doi=10.1016%2Fj.bmcl.2011.12.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DE.%2BC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DAmantea%26aufirst%3DC.%2BM.%26aulast%3DPham%26aufirst%3DL.%2BM.%26aulast%3DCajica%26aufirst%3DJ.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DH.%2BE.%26aulast%3DFraser%26aufirst%3DA.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DIshiyama%26aufirst%3DJ.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26aulast%3DShreder%26aufirst%3DK.%2BR.%26atitle%3DAmides%2520of%2520xanthurenic%2520acid%2520as%2520zinc-dependent%2520inhibitors%2520of%2520Lp-PLA%25282%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D868%26epage%3D871%26doi%3D10.1016%2Fj.bmcl.2011.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cajica, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amantea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreder, K. R.</span><span> </span><span class="NLM_article-title">Amides of 4-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic acid as zinc-dependent inhibitors of Lp-PLA(2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1553</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2012.11.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1553-1556&author=Y.+Huauthor=E.+C.+Linauthor=L.+M.+Phamauthor=J.+Cajicaauthor=C.+M.+Amanteaauthor=E.+Okerbergauthor=H.+E.+Brownauthor=A.+Fraserauthor=L.+Duauthor=Y.+Kohnoauthor=J.+Ishiyamaauthor=J.+W.+Kozarichauthor=K.+R.+Shreder&title=Amides+of+4-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic+acid+as+zinc-dependent+inhibitors+of+Lp-PLA%282%29&doi=10.1016%2Fj.bmcl.2012.11.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DE.%2BC.%26aulast%3DPham%26aufirst%3DL.%2BM.%26aulast%3DCajica%26aufirst%3DJ.%26aulast%3DAmantea%26aufirst%3DC.%2BM.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DH.%2BE.%26aulast%3DFraser%26aufirst%3DA.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DIshiyama%26aufirst%3DJ.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26aulast%3DShreder%26aufirst%3DK.%2BR.%26atitle%3DAmides%2520of%25204-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic%2520acid%2520as%2520zinc-dependent%2520inhibitors%2520of%2520Lp-PLA%25282%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1553%26epage%3D1556%26doi%3D10.1016%2Fj.bmcl.2012.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery of potent and orally active lipoprotein-associated phospholipase A2 (Lp-PLA<sub>2</sub>) inhibitors as a potential therapy for diabetic macular edema</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2687</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01930</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01930" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2674-2687&author=X.+Chenauthor=K.+Wangauthor=W.+Xuauthor=Q.+Maauthor=M.+Chenauthor=L.+Duauthor=M.+Moauthor=Y.+Wangauthor=J.+Shen&title=Discovery+of+potent+and+orally+active+lipoprotein-associated+phospholipase+A2+%28Lp-PLA2%29+inhibitors+as+a+potential+therapy+for+diabetic+macular+edema&doi=10.1021%2Facs.jmedchem.5b01930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14hR"><div class="casContent"><span class="casTitleNuber">14h</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema</span></div><div class="casAuthors">Chen, Xinde; Wang, Kai; Xu, Wenwei; Ma, Quanxin; Chen, Minli; Du, Lili; Mo, Mingguang; Wang, Yiping; Shen, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2674-2687</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoprotein-assocd. phospholipase A2 (Lp-PLA2) is considered to be a promising therapeutic target for several inflammation-assocd. diseases.  Herein, the authors describe the discovery of a series of pyrimidone derivs. as Lp-PLA2 inhibitors.  Systematic structural modifications led to the identification of several pyrimidone compds. with promising in vitro inhibitory potency and pharmacokinetic properties.  Compd. 2-(4-chloro-3-(trifluoromethyl)phenoxy)-5-(((1-methyl-6-morpholino-2-oxo-1,2-dihydropyrimidin-4-yl)oxy)methyl)benzonitrile (14c), selected for in vivo evaluation, demonstrated decent pharmacokinetic profiles and robust inhibitory potency against Lp-PLA2 in Sprague-Dawley (SD) rats.  Furthermore, (14c) significantly inhibited retinal thickening in STZ-induced diabetic SD rats as a model of diabetic macular edema (DME) after oral dosing for 4 wk.  Taken together, these results suggested that (14c) can serve as a valuable lead in the search for new Lp-PLA2 inhibitors for prevention and/or treatment of DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU6PK5PQKNZbVg90H21EOLACvtfcHk0lhhWAlGu4uBfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ynsL4%253D&md5=806cea713a349bfea27e3ecb9503d2ca</span></div><a href="/servlet/linkout?suffix=cit14h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01930%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DMo%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520orally%2520active%2520lipoprotein-associated%2520phospholipase%2520A2%2520%2528Lp-PLA2%2529%2520inhibitors%2520as%2520a%2520potential%2520therapy%2520for%2520diabetic%2520macular%2520edema%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2674%26epage%3D2687%26doi%3D10.1021%2Facs.jmedchem.5b01930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Samanta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnson, B. J.</span><span> </span><span class="NLM_article-title">Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">31617</span><span class="NLM_x">–</span> <span class="NLM_lpage">31624</span><span class="refDoi"> DOI: 10.1074/jbc.M804750200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1074%2Fjbc.M804750200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=31617-31624&author=U.+Samantaauthor=B.+J.+Bahnson&title=Crystal+structure+of+human+plasma+platelet-activating+factor+acetylhydrolase%3A+structural+implication+to+lipoprotein+binding+and+catalysis&doi=10.1074%2Fjbc.M804750200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M804750200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M804750200%26sid%3Dliteratum%253Aachs%26aulast%3DSamanta%26aufirst%3DU.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520human%2520plasma%2520platelet-activating%2520factor%2520acetylhydrolase%253A%2520structural%2520implication%2520to%2520lipoprotein%2520binding%2520and%2520catalysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D31617%26epage%3D31624%26doi%3D10.1074%2Fjbc.M804750200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Woolford, A. J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aravapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holding, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manas, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleland, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neipp, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potvain, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velagaleti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span> </span><span class="NLM_article-title">Exploitation of a novel binding pocket in human lipoprotein-associated phospholipase A2 (Lp-PLA<sub>2</sub>) discovered through X-ray fragment screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5356</span><span class="NLM_x">–</span> <span class="NLM_lpage">5367</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00212</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00212" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5356-5367&author=A.+J.-A.+Woolfordauthor=J.+E.+Peroauthor=S.+Aravapalliauthor=V.+Berdiniauthor=J.+E.+Coyleauthor=P.+J.+Dayauthor=A.+M.+Dodsonauthor=P.+Grondinauthor=F.+P.+Holdingauthor=L.+Y.+Leeauthor=P.+Liauthor=E.+S.+Manasauthor=J.+Marinoauthor=A.+C.+Martinauthor=B.+W.+McClelandauthor=R.+L.+McMenaminauthor=C.+W.+Murrayauthor=C.+E.+Neippauthor=L.+W.+Pageauthor=V.+K.+Patelauthor=F.+Potvainauthor=S.+Richauthor=R.+A.+Riveroauthor=K.+Smithauthor=D.+O.+Somersauthor=L.+Trottetauthor=R.+Velagaletiauthor=G.+Williamsauthor=R.+Xie&title=Exploitation+of+a+novel+binding+pocket+in+human+lipoprotein-associated+phospholipase+A2+%28Lp-PLA2%29+discovered+through+X-ray+fragment+screening&doi=10.1021%2Facs.jmedchem.6b00212"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00212%26sid%3Dliteratum%253Aachs%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DAravapalli%26aufirst%3DS.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDodson%26aufirst%3DA.%2BM.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DHolding%26aufirst%3DF.%2BP.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DMarino%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%2BC.%26aulast%3DMcCleland%26aufirst%3DB.%2BW.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DNeipp%26aufirst%3DC.%2BE.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DRich%26aufirst%3DS.%26aulast%3DRivero%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DVelagaleti%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DR.%26atitle%3DExploitation%2520of%2520a%2520novel%2520binding%2520pocket%2520in%2520human%2520lipoprotein-associated%2520phospholipase%2520A2%2520%2528Lp-PLA2%2529%2520discovered%2520through%2520X-ray%2520fragment%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5356%26epage%3D5367%26doi%3D10.1021%2Facs.jmedchem.6b00212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of protein-ligand interactions formed between lipoprotein-associated phospholipase A2 and inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5115</span><span class="NLM_x">–</span> <span class="NLM_lpage">5120</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5115-5120&author=Q.+Liuauthor=X.+Chenauthor=W.+Chenauthor=X.+Yuanauthor=H.+Suauthor=J.+Shenauthor=Y.+Xu&title=Structural+and+thermodynamic+characterization+of+protein-ligand+interactions+formed+between+lipoprotein-associated+phospholipase+A2+and+inhibitors&doi=10.1021%2Facs.jmedchem.6b00282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of Protein-Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors</span></div><div class="casAuthors">Liu, Qiufeng; Chen, Xinde; Chen, Wuyan; Yuan, Xiaojing; Su, Haixia; Shen, Jianhua; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5115-5120</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoprotein-assocd. phospholipase A2 (Lp-PLA2) represents a promising therapeutic target for atherosclerosis and Alzheimer's disease.  Here we reported the first crystal structures of Lp-PLA2 bound with reversible inhibitors and the thermodn. characterization of complexes.  High rigidity of Lp-PLA2 structure and similar binding modes of inhibitors with completely different scaffolds are revealed.  It not only provides the mol. basis for inhibitory activity but also sheds light on the essential features of Lp-PLA2 recognition with reversible inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrT-MldsDJs7Vg90H21EOLACvtfcHk0lhthY349V-Q7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL4%253D&md5=a929a163f8dc8652f790736f5c3bd0ac</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00282%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520protein-ligand%2520interactions%2520formed%2520between%2520lipoprotein-associated%2520phospholipase%2520A2%2520and%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5115%26epage%3D5120%26doi%3D10.1021%2Facs.jmedchem.6b00282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">SB-480848. GlaxoSmithKline</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=348-351&author=D.+P.+Rotella&title=SB-480848.+GlaxoSmithKline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DSB-480848.%2520GlaxoSmithKline%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D348%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span>CLOGP, v4.93, <span class="NLM_publisher-name">Daylight Chemical Information Systems, Inc.</span>: <span class="NLM_publisher-loc">Laguna Niguel, CA</span>. <a href="http://www.daylight.com/dayhtml/doc/clogp/" class="extLink">http://www.daylight.com/dayhtml/doc/clogp/</a> (accessed 26th October,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CLOGP%2C+v4.93%2C+Daylight+Chemical+Information+Systems%2C+Inc.%3A+Laguna+Niguel%2C+CA.+http%3A%2F%2Fwww.daylight.com%2Fdayhtml%2Fdoc%2Fclogp%2F+%28accessed+26th+October%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCLOGP%26pub%3DDaylight%2520Chemical%2520Information%2520Systems%252C%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lhthY349V-Q7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wenlock, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">A comparison of physiochemical property profiles of development and marketed oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span><span class="refDoi"> DOI: 10.1021/jm021053p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&author=M.+C.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+comparison+of+physiochemical+property+profiles+of+development+and+marketed+oral+drugs&doi=10.1021%2Fjm021053p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0lgcf6ep2t2qMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520comparison%2520of%2520physiochemical%2520property%2520profiles%2520of%2520development%2520and%2520marketed%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1250%26epage%3D1256%26doi%3D10.1021%2Fjm021053p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lgcf6ep2t2qMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Recombinant human Lp-PLA<sub>2</sub> PED6 assay using a PED6 fluorogenic substrate (employed for the weaker inhibitors). See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgrumFISxbbkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">Ligand efficiency (LE) = – Δ<i>G</i>/HAC ≈ −<i>RT</i> ln(IC<sub>50</sub>)/HAC (units = kcal mol<sup>–1</sup> per heavy atom).</p></div><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZBAXDYGbBKMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">Group efficiency (GE) = −ΔΔ<i>G</i>/ΔHAC (units = kcal mol<sup>–1</sup> per non-hydrogen atom).</p></div><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">Group efficiency: a guideline for hits-to-leads chemistry</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span><span class="refDoi"> DOI: 10.1002/cmdc.200800132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1002%2Fcmdc.200800132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1179-1180&author=M.+L.+Verdonkauthor=D.+C.+Rees&title=Group+efficiency%3A+a+guideline+for+hits-to-leads+chemistry&doi=10.1002%2Fcmdc.200800132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800132%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DGroup%2520efficiency%253A%2520a%2520guideline%2520for%2520hits-to-leads%2520chemistry%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1179%26epage%3D1180%26doi%3D10.1002%2Fcmdc.200800132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':[],'ref12':[],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f','cit14g','cit14h'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':[],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Cedric L. Hugelshofer, Jianming Bao, Juana Du, Eric Ashley, Wensheng Yu, Tao Ji, Bin Hu, Dejun Liu, Ramu Rondla, Srinivas Karampuri, Vishal Sharma, Krishna Ethiraj, <span class="NLM_string-name hlFld-ContribAuthor">Yeon-Hee Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable Preparation of 4,4-Disubstituted Six-Membered Cyclic Sulfones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 943-947. <a href="https://doi.org/10.1021/acs.orglett.0c04141" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04141%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DScalable%252BPreparation%252Bof%252B4%25252C4-Disubstituted%252BSix-Membered%252BCyclic%2525C2%2525A0Sulfones%26aulast%3DHugelshofer%26aufirst%3DCedric%2BL.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15122020%26date%3D08012021%26volume%3D23%26issue%3D3%26spage%3D943%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haixia Su, Yi Zou, Guofeng Chen, Huixia Dou, Hang Xie, Xiaojing Yuan, Xianglei Zhang, Naixia Zhang, Minjun Li, <span class="NLM_string-name hlFld-ContribAuthor">Yechun Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 4090-4106. <a href="https://doi.org/10.1021/acs.jmedchem.9b02107" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02107%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252BFragment%252BBinding%252BPoses%252BLeading%252Bto%252BEfficient%252BDiscovery%252Bof%252BHighly%252BPotent%252Band%252BOrally%252BEffective%252BInhibitors%252Bof%252BFABP4%252Bfor%252BAnti-inflammation%26aulast%3DSu%26aufirst%3DHaixia%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18122019%26date%3D10042020%26date%3D23032020%26volume%3D63%26issue%3D8%26spage%3D4090%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan He, Zhi Zheng, Yajie Liu, Jiajie Qiao, Xinying Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xuesen Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Cleavage and Tunable Functionalization of the C–C/C–N Bonds of N-Arylpiperidines Promoted by tBuONO. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (6)
                                     , 1676-1680. <a href="https://doi.org/10.1021/acs.orglett.9b00226" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00226%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSelective%252BCleavage%252Band%252BTunable%252BFunctionalization%252Bof%252Bthe%252BC%2525E2%252580%252593C%25252FC%2525E2%252580%252593N%252BBonds%252Bof%252BN-Arylpiperidines%252BPromoted%252Bby%252BtBuONO%26aulast%3DHe%26aufirst%3DYan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18012019%26date%3D04032019%26volume%3D21%26issue%3D6%26spage%3D1676%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher N. Johnson, Daniel A. Erlanson, Wolfgang Jahnke, Paul N. Mortenson, <span class="NLM_string-name hlFld-ContribAuthor">David C. Rees</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2016. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1774-1784. <a href="https://doi.org/10.1021/acs.jmedchem.7b01298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2016%26aulast%3DJohnson%26aufirst%3DChristopher%2BN.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D31082017%26date%3D31102017%26volume%3D61%26issue%3D5%26spage%3D1774%26epage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiufeng  Liu</span>, <span class="hlFld-ContribAuthor ">Fubao  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Yuan</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Zou</span>, <span class="hlFld-ContribAuthor ">Jianhua  Shen</span>, and <span class="hlFld-ContribAuthor ">Yechun  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10231-10244. <a href="https://doi.org/10.1021/acs.jmedchem.7b01530" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01530%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDiscovery%252Bof%252BNovel%25252C%252BPotent%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252BLipoprotein-Associated%252BPhospholipase%252BA2%26aulast%3DLiu%26aufirst%3DQiufeng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15102017%26date%3D15122017%26date%3D28122017%26date%3D01122017%26volume%3D60%26issue%3D24%26spage%3D10231%26epage%3D10244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charikleia S.  Batsika</span>, <span class="hlFld-ContribAuthor ">Anna-Dimitra D.  Gerogiannopoulou</span>, <span class="hlFld-ContribAuthor ">Christiana  Mantzourani</span>, <span class="hlFld-ContribAuthor ">Sofia  Vasilakaki</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">The design and discovery of phospholipase A
              2
              inhibitors for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>340 </em>, 1-19. <a href="https://doi.org/10.1080/17460441.2021.1942835" title="DOI URL">https://doi.org/10.1080/17460441.2021.1942835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1942835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1942835%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bdesign%252Band%252Bdiscovery%252Bof%252Bphospholipase%252BA%252B2%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DBatsika%26aufirst%3DCharikleia%2BS.%26date%3D2021%26date%3D2021%26volume%3D340%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fubao  Huang</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Jianhua  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Lipoprotein‐associated phospholipase A2: The story continues. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 79-134. <a href="https://doi.org/10.1002/med.21597" title="DOI URL">https://doi.org/10.1002/med.21597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21597%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DLipoprotein%2525E2%252580%252590associated%252Bphospholipase%252BA2%25253A%252BThe%252Bstory%252Bcontinues%26aulast%3DHuang%26aufirst%3DFubao%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D79%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuno R.  Candeias</span>, <span class="hlFld-ContribAuthor ">Alexander  Efimov</span>. </span><span class="cited-content_cbyCitation_article-title">Thiopyrans and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00020-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00020-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00020-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00020-2%26sid%3Dliteratum%253Aachs%26atitle%3DThiopyrans%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DCandeias%26aufirst%3DNuno%2BR.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aikaterini  Nikolaou</span>, <span class="hlFld-ContribAuthor ">Maroula G.  Kokotou</span>, <span class="hlFld-ContribAuthor ">Sofia  Vasilakaki</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2019,</strong> <em>1864 </em>
                                    (6)
                                     , 941-956. <a href="https://doi.org/10.1016/j.bbalip.2018.08.009" title="DOI URL">https://doi.org/10.1016/j.bbalip.2018.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2018.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DSmall-molecule%252Binhibitors%252Bas%252Bpotential%252Btherapeutics%252Band%252Bas%252Btools%252Bto%252Bunderstand%252Bthe%252Brole%252Bof%252Bphospholipases%252BA2%26aulast%3DNikolaou%26aufirst%3DAikaterini%26date%3D2019%26volume%3D1864%26issue%3D6%26spage%3D941%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) X-ray crystal structure of darapladib (<b>1</b>) bound to Lp-PLA<sub>2</sub>. The Connolly surface of darapladib is shown in solid purple and the protein as a gray mesh. (b) Superposition of the X-ray crystal structures of uracil <b>2</b> (cyan), hydantoin <b>3</b> (magenta), and sulfonamide <b>4</b> (green) bound to Lp-PLA<sub>2</sub>. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structures of compounds <b>2</b>–<b>4</b> bound to Lp-PLA<sub>2</sub>; uracil <b>2</b> (cyan) is a fragment hit that binds adjacent to the catalytic residues Ser273, His351, and Asp296; hydantoin <b>3</b> (magenta) is a fragment hit that is bound in the oxyanion hole; and sulfonamide <b>4</b> (green) is derived from a fragment hit.<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> The Connolly surface of the protein is shown as a gray mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines, and water is shown as gray spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic design process. Moieties within the compounds are colored according to the original compound from which they are derived. a: rhLp-PLA<sub>2</sub> PED6 assay. b: rhLp-PLA<sub>2</sub> Thio-PAF assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of hydantoin <b>5</b> bound in Lp-PLA<sub>2</sub>. The Connolly surface of the ligand is shown in solid orange and the protein as a gray mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of lactam <b>13</b> in complex with Lp-PLA<sub>2</sub>. The Connolly surface of the ligand is shown as an orange mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines, and a water molecule is shown as a gray sphere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Superposition of the X-ray crystal structures of lactams <b>(</b><i><b>S</b></i><b>)-15</b> (green) and <b>(</b><i><b>R</b></i><b>)-15</b> (orange), each in complex with Lp-PLA<sub>2</sub>. The Connolly surfaces of the ligands are shown as a mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystal structure of Lp-PLA<sub>2</sub> in complex with the (<i>S</i>)-enantiomer of <b>(±)-18</b>. The Connolly surface of the ligand is shown in solid orange and the protein as a gray mesh. Selected residues are shown for clarity. The hydrogen bond interactions are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Group efficiency (GE = kcal mol<sup>–1</sup> per non-hydrogen atom) schematic for compound <b>(±)-23</b> based on pairwise comparisons (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). GE ≥ 0.3 is considered desirable.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray crystal structure of Lp-PLA<sub>2</sub> in complex with lactam <b>(</b><i><b>S</b></i><b>)-23</b>. The Connolly surface of the ligand is shown in solid orange and the protein as a gray mesh. Selected residues are shown for clarity. Hydrogen bond interactions are represented as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Superposition of the X-ray crystal structures of uracil <b>2</b> (cyan), hydantoin <b>3</b> (magenta), sulfonamide <b>4</b> (green) (only showing the Connolly surface as a mesh), and <b>(</b><i><b>S</b></i><b>)-23</b> (orange), bound in Lp-PLA<sub>2</sub>. (b) Superposition of the crystal structures of <b>(</b><i><b>S</b></i><b>)-23</b> (orange) and darapladib (purple) bound in Lp-PLA<sub>2</sub>. Only selected residues are shown for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lactam Intermediate <b>(±)-31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeI, <i>t</i>-BuOK, THF, 0 °C, 2 h, 94%; (b) triethyl phosphonoacetate, <i>t</i>-BuOK, THF, 0 °C, 3 h, 96%; (c) nitromethane, 1,1,3,3-tetramethylguanidine, 100 °C (microwave), 4 h, 43%; (d) NiCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH, 0 °C, 1.5 h, 65%.</p></p></figure><figure data-id="sch2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/medium/jm-2016-014272_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfone <b>(±)-23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01427/20161202/images/large/jm-2016-014272_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01427&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethylene carbonate, K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C, 18 h, 92%; (b) Ms-Cl, Et<sub>3</sub>N, THF, 0 °C, 0.5 h, 88%; (c) NaH, DMF, 40 °C, 18 h, 44%; (d) mCPBA, DCM, 25 °C, 4 h, 66%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Six, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, E. A.</span><span> </span><span class="NLM_article-title">The expanding superfamily of phospholipase A(2) enzymes: classification and characterization</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1488</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1016/S1388-1981(00)00105-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS1388-1981%2800%2900105-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=11080672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlGisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1488&publication_year=2000&pages=1-19&author=D.+A.+Sixauthor=E.+A.+Dennis&title=The+expanding+superfamily+of+phospholipase+A%282%29+enzymes%3A+classification+and+characterization&doi=10.1016%2FS1388-1981%2800%2900105-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The expanding superfamily of phospholipase A2 enzymes: classification and characterization</span></div><div class="casAuthors">Six, D. A.; Dennis, E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1488</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review and discussion with 189 refs.  The phospholipase A2 (PLA2) superfamily consists of a broad range of enzymes defined by their ability to catalyze the hydrolysis of the middle (sn-2) ester bond of substrate phospholipids.  The hydrolysis products of this reaction, free fatty acid and lysophospholipid, have many important downstream roles, and are derived from the activity of a diverse and growing superfamily of PLA2 enzymes.  This review updates the classification of the various PLA2's now described in the literature.  Four criteria have been employed to classify these proteins into one of the 11 groups (I-XI) of PLA2's.  First, the enzyme must catalyze the hydrolysis of the sn-2 ester bond of a natural phospholipid substrate, such as long fatty acid chain phospholipids, platelet activating factor, or short fatty acid chain oxidized phospholipids.  Second, the complete amino acid sequence of the mature protein must be known.  Third, each PLA2 group should include all of those enzymes that have readily identifiable sequence homol.  If more than one homologous PLA2 gene exists within a species, then each paralog should be assigned a subgroup letter, as in the case of group IVA, IVB, and IVC PLA2.  Homologs from different species should be classified within the same subgroup wherever such assignments are possible as is the case with zebra fish and human group IVA PLA2 orthologs.  The current classification scheme does allow for historical exceptions of the highly homologous group I, II, V, and X PLA2's.  Fourth, catalytically active splice variants of the same gene are classified as the same group and subgroup, but distinguished using Arabic nos., such as for group VIA-1 PLA2 and VIA-2 PLA2's.  These 4 criteria have led to the expansion or realignment of groups VI, VII and VIII, as well as the addn. of group XI PLA2 from plants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8DKWoAZlTrVg90H21EOLACvtfcHk0lh9khuCnhgkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlGisbo%253D&md5=70fc2db5490a692b8b961fa40e543d6f</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2800%2900105-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252800%252900105-0%26sid%3Dliteratum%253Aachs%26aulast%3DSix%26aufirst%3DD.%2BA.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26atitle%3DThe%2520expanding%2520superfamily%2520of%2520phospholipase%2520A%25282%2529%2520enzymes%253A%2520classification%2520and%2520characterization%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2000%26volume%3D1488%26spage%3D1%26epage%3D19%26doi%3D10.1016%2FS1388-1981%2800%2900105-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schaloske, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, E. A.</span><span> </span><span class="NLM_article-title">The phospholipase A2 superfamily and its group numbering system</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1761</span><span class="NLM_x">, </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1259</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2006.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bbalip.2006.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=16973413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CisLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1761&publication_year=2006&pages=1246-1259&author=R.+H.+Schaloskeauthor=E.+A.+Dennis&title=The+phospholipase+A2+superfamily+and+its+group+numbering+system&doi=10.1016%2Fj.bbalip.2006.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The phospholipase A2 superfamily and its group numbering system</span></div><div class="casAuthors">Schaloske, Ralph H.; Dennis, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1761</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1246-1259</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The superfamily of phospholipase A2 (PLA2) enzymes currently consists of 15 groups and many subgroups and includes 5 distinct types of enzymes, namely the secretory PLA2s (sPLA2), the cytosolic PLA2s (cPLA2), the Ca2+-independent PLA2s (iPLA2), the platelet-activating factor acetylhydrolases (PAF-AH), and the lysosomal PLA2s.  In 1994, the authors established the systematic group numbering system for these enzymes.  Since then, the PLA2 superfamily has grown continuously and over the intervening years has required several updates of this group numbering system.  Since the last update, a no. of new PLA2s have been discovered and are now included.  Addnl., tools for the investigation of PLA2s and approaches for distinguishing between the different groups are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zJ1-ln1MRbVg90H21EOLACvtfcHk0lhQ1vt9X7UX0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CisLvM&md5=0c7b3bfc7e061cfb62b1ba5659c2e0b9</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2006.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2006.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DSchaloske%26aufirst%3DR.%2BH.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26atitle%3DThe%2520phospholipase%2520A2%2520superfamily%2520and%2520its%2520group%2520numbering%2520system%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2006%26volume%3D1761%26spage%3D1246%26epage%3D1259%26doi%3D10.1016%2Fj.bbalip.2006.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Stafforini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, S. M.</span><span> </span><span class="NLM_article-title">Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">4215</span><span class="NLM_x">–</span> <span class="NLM_lpage">4222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=4215-4222&author=D.+M.+Stafforiniauthor=T.+M.+McIntyreauthor=M.+E.+Carterauthor=S.+M.+Prescott&title=Human+plasma+platelet-activating+factor+acetylhydrolase.+Association+with+lipoprotein+particles+and+role+in+the+degradation+of+platelet-activating+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStafforini%26aufirst%3DD.%2BM.%26aulast%3DMcIntyre%26aufirst%3DT.%2BM.%26aulast%3DCarter%26aufirst%3DM.%2BE.%26aulast%3DPrescott%26aufirst%3DS.%2BM.%26atitle%3DHuman%2520plasma%2520platelet-activating%2520factor%2520acetylhydrolase.%2520Association%2520with%2520lipoprotein%2520particles%2520and%2520role%2520in%2520the%2520degradation%2520of%2520platelet-activating%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D4215%26epage%3D4222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stremler, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafforini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, T. M.</span><span> </span><span class="NLM_article-title">An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">5331</span><span class="NLM_x">–</span> <span class="NLM_lpage">5334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=5331-5334&author=K.+E.+Stremlerauthor=D.+M.+Stafforiniauthor=S.+M.+Prescottauthor=G.+A.+Zimmermanauthor=T.+M.+McIntyre&title=An+oxidized+derivative+of+phosphatidylcholine+is+a+substrate+for+the+platelet-activating+factor+acetylhydrolase+from+human+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStremler%26aufirst%3DK.%2BE.%26aulast%3DStafforini%26aufirst%3DD.%2BM.%26aulast%3DPrescott%26aufirst%3DS.%2BM.%26aulast%3DZimmerman%26aufirst%3DG.%2BA.%26aulast%3DMcIntyre%26aufirst%3DT.%2BM.%26atitle%3DAn%2520oxidized%2520derivative%2520of%2520phosphatidylcholine%2520is%2520a%2520substrate%2520for%2520the%2520platelet-activating%2520factor%2520acetylhydrolase%2520from%2520human%2520plasma%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D5331%26epage%3D5334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stremler, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafforini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, T. M.</span><span> </span><span class="NLM_article-title">Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">11095</span><span class="NLM_x">–</span> <span class="NLM_lpage">11103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=11095-11103&author=K.+E.+Stremlerauthor=D.+M.+Stafforiniauthor=S.+M.+Prescottauthor=T.+M.+McIntyre&title=Human+plasma+platelet-activating+factor+acetylhydrolase.+Oxidatively+fragmented+phospholipids+as+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStremler%26aufirst%3DK.%2BE.%26aulast%3DStafforini%26aufirst%3DD.%2BM.%26aulast%3DPrescott%26aufirst%3DS.%2BM.%26aulast%3DMcIntyre%26aufirst%3DT.%2BM.%26atitle%3DHuman%2520plasma%2520platelet-activating%2520factor%2520acetylhydrolase.%2520Oxidatively%2520fragmented%2520phospholipids%2520as%2520substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D11095%26epage%3D11103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">MacPhee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moores, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leake, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milliner, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckling, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span> </span><span class="NLM_article-title">Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x"> (</span><span class="NLM_issue">Pt 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1042/0264-6021:3380479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1042%2F0264-6021%3A3380479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1999&pages=479-487&issue=Pt+2&author=C.+H.+MacPheeauthor=K.+E.+Mooresauthor=H.+F.+Boydauthor=D.+Dhanakauthor=R.+J.+Ifeauthor=C.+A.+Leachauthor=D.+S.+Leakeauthor=K.+J.+Millinerauthor=R.+A.+Pattersonauthor=K.+E.+Sucklingauthor=D.+G.+Tewauthor=D.+M.+Hickey&title=Lipoprotein-associated+phospholipase+A2%2C+platelet-activating+factor+acetylhydrolase%2C+generates+two+bioactive+products+during+the+oxidation+of+low-density+lipoprotein%3A+use+of+a+novel+inhibitor&doi=10.1042%2F0264-6021%3A3380479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1042%2F0264-6021%3A3380479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252F0264-6021%253A3380479%26sid%3Dliteratum%253Aachs%26aulast%3DMacPhee%26aufirst%3DC.%2BH.%26aulast%3DMoores%26aufirst%3DK.%2BE.%26aulast%3DBoyd%26aufirst%3DH.%2BF.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26aulast%3DLeake%26aufirst%3DD.%2BS.%26aulast%3DMilliner%26aufirst%3DK.%2BJ.%26aulast%3DPatterson%26aufirst%3DR.%2BA.%26aulast%3DSuckling%26aufirst%3DK.%2BE.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26atitle%3DLipoprotein-associated%2520phospholipase%2520A2%252C%2520platelet-activating%2520factor%2520acetylhydrolase%252C%2520generates%2520two%2520bioactive%2520products%2520during%2520the%2520oxidation%2520of%2520low-density%2520lipoprotein%253A%2520use%2520of%2520a%2520novel%2520inhibitor%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D338%26issue%3DPt%25202%26spage%3D479%26epage%3D487%26doi%3D10.1042%2F0264-6021%3A3380479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orfei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Angelantonio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptoge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criqui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danesh, J.</span><span> </span><span class="NLM_article-title">Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">1536</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)60319-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS0140-6736%2810%2960319-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=1536-1544&author=A.+Thompsonauthor=P.+Gaoauthor=L.+Orfeiauthor=S.+Watsonauthor=E.+Di+Angelantonioauthor=S.+Kaptogeauthor=C.+Ballantyneauthor=C.+P.+Cannonauthor=M.+Criquiauthor=M.+Cushmanauthor=A.+Hofmanauthor=C.+Packardauthor=S.+G.+Thompsonauthor=R.+Collinsauthor=J.+Danesh&title=Lipoprotein-associated+phospholipase+A%282%29+and+risk+of+coronary+disease%2C+stroke%2C+and+mortality%3A+collaborative+analysis+of+32+prospective+studies&doi=10.1016%2FS0140-6736%2810%2960319-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2960319-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252960319-4%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DOrfei%26aufirst%3DL.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DDi%2BAngelantonio%26aufirst%3DE.%26aulast%3DKaptoge%26aufirst%3DS.%26aulast%3DBallantyne%26aufirst%3DC.%26aulast%3DCannon%26aufirst%3DC.%2BP.%26aulast%3DCriqui%26aufirst%3DM.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DHofman%26aufirst%3DA.%26aulast%3DPackard%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DS.%2BG.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DDanesh%26aufirst%3DJ.%26atitle%3DLipoprotein-associated%2520phospholipase%2520A%25282%2529%2520and%2520risk%2520of%2520coronary%2520disease%252C%2520stroke%252C%2520and%2520mortality%253A%2520collaborative%2520analysis%2520of%252032%2520prospective%2520studies%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D1536%26epage%3D1544%26doi%3D10.1016%2FS0140-6736%2810%2960319-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fitzpatrick, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irizarry, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koro, C.</span><span> </span><span class="NLM_article-title">Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.atherosclerosis.2014.04.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2014&pages=384-391&author=A.+L.+Fitzpatrickauthor=M.+C.+Irizarryauthor=M.+Cushmanauthor=N.+S.+Jennyauthor=G.+C.+Chiauthor=C.+Koro&title=Lipoprotein-associated+phospholipase+A2+and+risk+of+dementia+in+the+Cardiovascular+Health+Study&doi=10.1016%2Fj.atherosclerosis.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DA.%2BL.%26aulast%3DIrizarry%26aufirst%3DM.%2BC.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DJenny%26aufirst%3DN.%2BS.%26aulast%3DChi%26aufirst%3DG.%2BC.%26aulast%3DKoro%26aufirst%3DC.%26atitle%3DLipoprotein-associated%2520phospholipase%2520A2%2520and%2520risk%2520of%2520dementia%2520in%2520the%2520Cardiovascular%2520Health%2520Study%26jtitle%3DAtherosclerosis%26date%3D2014%26volume%3D235%26spage%3D384%26epage%3D391%26doi%3D10.1016%2Fj.atherosclerosis.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Staurenghi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurzelmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span> </span><span class="NLM_article-title">Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study</span> <span class="citation_source-journal">Ophthalmology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1016/j.ophtha.2014.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.ophtha.2014.12.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2015&pages=990-996&author=G.+Staurenghiauthor=L.+Yeauthor=M.+H.+Mageeauthor=R.+P.+Danisauthor=J.+Wurzelmannauthor=P.+Adamsonauthor=M.+M.+McLaughlin&title=Darapladib%2C+a+lipoprotein-associated+phospholipase+A2+inhibitor%2C+in+diabetic+macular+edema%3A+a+3-month+placebo-controlled+study&doi=10.1016%2Fj.ophtha.2014.12.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ophtha.2014.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ophtha.2014.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DStaurenghi%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DMagee%26aufirst%3DM.%2BH.%26aulast%3DDanis%26aufirst%3DR.%2BP.%26aulast%3DWurzelmann%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DP.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26atitle%3DDarapladib%252C%2520a%2520lipoprotein-associated%2520phospholipase%2520A2%2520inhibitor%252C%2520in%2520diabetic%2520macular%2520edema%253A%2520a%25203-month%2520placebo-controlled%2520study%26jtitle%3DOphthalmology%26date%3D2015%26volume%3D122%26spage%3D990%26epage%3D996%26doi%3D10.1016%2Fj.ophtha.2014.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vainio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpindi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohonen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaegh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alanen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iljin, K.</span><span> </span><span class="NLM_article-title">Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2010.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.ajpath.2010.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=21281786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVOlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2011&pages=525-536&author=P.+Vainioauthor=S.+Guptaauthor=K.+Ketolaauthor=T.+Mirttiauthor=J.+P.+Mpindiauthor=P.+Kohonenauthor=V.+Feyauthor=M.+Peralaauthor=F.+Smitauthor=G.+Verhaeghauthor=J.+Schalkenauthor=K.+A.+Alanenauthor=O.+Kallioniemiauthor=K.+Iljin&title=Arachidonic+acid+pathway+members+PLA2G7%2C+HPGD%2C+EPHX2%2C+and+CYP4F8+identified+as+putative+novel+therapeutic+targets+in+prostate+cancer&doi=10.1016%2Fj.ajpath.2010.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer</span></div><div class="casAuthors">Vainio, Paula; Gupta, Santosh; Ketola, Kirsi; Mirtti, Tuomas; Mpindi, John-Patrick; Kohonen, Pekka; Fey, Vidal; Perala, Merja; Smit, Frank; Verhaegh, Gerald; Schalken, Jack; Alanen, Kalle A.; Kallioniemi, Olli; Iljin, Kristiina</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-536</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The arachidonic acid and prostaglandin pathway has been implicated in prostate carcinogenesis, but comprehensive studies of the individual members in this key pathway are lacking.  Here, we first conducted a systematic bioinformatic study of the expression of 36 arachidonic acid pathway genes across 9783 human tissue samples.  The results showed that the PLA2G7, HPGD, EPHX2, and CYP4F8 genes are highly expressed in prostate cancer.  Functional studies using RNA interference in prostate cancer cells indicated that all four genes are also essential for cell growth and survival.  Clin. validation confirmed high PLA2G7 expression, esp. in ERG oncogene-pos. prostate cancers, and its silencing sensitized ERG-pos. prostate cancer cells to oxidative stress.  HPGD was highly expressed in androgen receptor (AR)-overexpressing advanced tumors, as well as in metastatic prostate cancers.  EPHX2 mRNA correlated with AR in primary prostate cancers, and its inhibition in vitro reduced AR signaling and potentiated the effect of antiandrogen flutamide in cultured prostate cancer cells.  In summary, we identified four novel putative therapeutic targets with biomarker potential for different subtypes of prostate cancer.  In addn., our results indicate that inhibition of these enzymes may be particularly powerful when combined with other treatments, such as androgen deprivation or induction of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreGcJNZN3L4LVg90H21EOLACvtfcHk0liun88Jkb-Mkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVOlsbs%253D&md5=151d70302659b8efe677b1ee7a912635</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2010.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2010.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DVainio%26aufirst%3DP.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DKetola%26aufirst%3DK.%26aulast%3DMirtti%26aufirst%3DT.%26aulast%3DMpindi%26aufirst%3DJ.%2BP.%26aulast%3DKohonen%26aufirst%3DP.%26aulast%3DFey%26aufirst%3DV.%26aulast%3DPerala%26aufirst%3DM.%26aulast%3DSmit%26aufirst%3DF.%26aulast%3DVerhaegh%26aufirst%3DG.%26aulast%3DSchalken%26aufirst%3DJ.%26aulast%3DAlanen%26aufirst%3DK.%2BA.%26aulast%3DKallioniemi%26aufirst%3DO.%26aulast%3DIljin%26aufirst%3DK.%26atitle%3DArachidonic%2520acid%2520pathway%2520members%2520PLA2G7%252C%2520HPGD%252C%2520EPHX2%252C%2520and%2520CYP4F8%2520identified%2520as%2520putative%2520novel%2520therapeutic%2520targets%2520in%2520prostate%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D178%26spage%3D525%26epage%3D536%26doi%3D10.1016%2Fj.ajpath.2010.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vainio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtinen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seppanen-Laakso, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virtanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rannikko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oresic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iljin, K.</span><span> </span><span class="NLM_article-title">Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span><span class="refDoi"> DOI: 10.18632/oncotarget.397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.18632%2Foncotarget.397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1176-1190&author=P.+Vainioauthor=L.+Lehtinenauthor=T.+Mirttiauthor=M.+Hilvoauthor=T.+Seppanen-Laaksoauthor=J.+Virtanenauthor=A.+Sankilaauthor=S.+Nordlingauthor=J.+Lundinauthor=A.+Rannikkoauthor=M.+Oresicauthor=O.+Kallioniemiauthor=K.+Iljin&title=Phospholipase+PLA2G7%2C+associated+with+aggressive+prostate+cancer%2C+promotes+prostate+cancer+cell+migration+and+invasion+and+is+inhibited+by+statins&doi=10.18632%2Foncotarget.397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.397%26sid%3Dliteratum%253Aachs%26aulast%3DVainio%26aufirst%3DP.%26aulast%3DLehtinen%26aufirst%3DL.%26aulast%3DMirtti%26aufirst%3DT.%26aulast%3DHilvo%26aufirst%3DM.%26aulast%3DSeppanen-Laakso%26aufirst%3DT.%26aulast%3DVirtanen%26aufirst%3DJ.%26aulast%3DSankila%26aufirst%3DA.%26aulast%3DNordling%26aufirst%3DS.%26aulast%3DLundin%26aufirst%3DJ.%26aulast%3DRannikko%26aufirst%3DA.%26aulast%3DOresic%26aufirst%3DM.%26aulast%3DKallioniemi%26aufirst%3DO.%26aulast%3DIljin%26aufirst%3DK.%26atitle%3DPhospholipase%2520PLA2G7%252C%2520associated%2520with%2520aggressive%2520prostate%2520cancer%252C%2520promotes%2520prostate%2520cancer%2520cell%2520migration%2520and%2520invasion%2520and%2520is%2520inhibited%2520by%2520statins%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D1176%26epage%3D1190%26doi%3D10.18632%2Foncotarget.397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bertilsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessem, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viset, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribbestad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgunset, J.</span><span> </span><span class="NLM_article-title">Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3261</span><span class="NLM_x">–</span> <span class="NLM_lpage">3269</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-2929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1158%2F1078-0432.CCR-11-2929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=22510345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1Oltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=3261-3269&author=H.+Bertilssonauthor=M.+B.+Tessemauthor=A.+Flatbergauthor=T.+Visetauthor=I.+Gribbestadauthor=A.+Angelsenauthor=J.+Halgunset&title=Changes+in+gene+transcription+underlying+the+aberrant+citrate+and+choline+metabolism+in+human+prostate+cancer+samples&doi=10.1158%2F1078-0432.CCR-11-2929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in Gene Transcription Underlying the Aberrant Citrate and Choline Metabolism in Human Prostate Cancer Samples</span></div><div class="casAuthors">Bertilsson, Helena; Tessem, May-Britt; Flatberg, Arnar; Viset, Trond; Gribbestad, Ingrid; Angelsen, Anders; Halgunset, Jostein</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3261-3269</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Low concns. of citrate and high concns. of choline-contg. compds. (ChoCC) are metabolic characteristics obsd. by magnetic resonance spectroscopy of prostate cancer tissue.  The objective was to investigate the gene expression changes underlying these metabolic aberrations to find regulatory genes with potential for targeted therapies.  Exptl. design: Fresh frozen samples (n = 133) from 41 patients undergoing radical prostatectomy were included.  Histopathol. evaluation was carried out for each sample before a metabolic profile was obtained with high-resoln. magic angle spinning (HR-MAS) spectroscopy.  Following the HR-MAS, RNA was extd. from the same sample and quality controlled before carrying out microarray gene expression profiling.  A partial least square statistical model was used to integrate the data sets to identify genes whose expression show significant covariance with citrate and ChoCC levels.  Results: Samples were classified as benign, n = 35; cancer of low grade (Gleason score 6), n = 24; intermediate grade (Gleason score 7), n = 41; or high grade (Gleason score ≥8), n = 33.  RNA quality was high with a mean RNA Integrity No. score of 9.1 (SD 1.2).  Gene products predicting significantly a reduced citrate level were acetyl citrate lyase (ACLY, P = 0.003) and m-aconitase (ACON, P < 0.001).  The two genes whose expression most closely accompanied the increase in ChoCC were those of phospholipase A2 group VII (PLA2G7, P < 0.001) and choline kinase α (CHKA, P = 0.002).  Conclusions: By integrating histol., transcriptomic, and metabolic data, our study has contributed to an expanded understanding of the mechanisms underlying aberrant citrate and ChoCC levels in prostate cancer.  Clin Cancer Res; 18(12); 3261-9. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWms-kGf7vGrVg90H21EOLACvtfcHk0lj4wcZFsQvmgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1Oltb8%253D&md5=9e6b8df07ca73835ece816dde841fba6</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2929%26sid%3Dliteratum%253Aachs%26aulast%3DBertilsson%26aufirst%3DH.%26aulast%3DTessem%26aufirst%3DM.%2BB.%26aulast%3DFlatberg%26aufirst%3DA.%26aulast%3DViset%26aufirst%3DT.%26aulast%3DGribbestad%26aufirst%3DI.%26aulast%3DAngelsen%26aufirst%3DA.%26aulast%3DHalgunset%26aufirst%3DJ.%26atitle%3DChanges%2520in%2520gene%2520transcription%2520underlying%2520the%2520aberrant%2520citrate%2520and%2520choline%2520metabolism%2520in%2520human%2520prostate%2520cancer%2520samples%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D3261%26epage%3D3269%26doi%3D10.1158%2F1078-0432.CCR-11-2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Serruys, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Garcia, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buszman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botker, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Birgelen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambanini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastik, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Es, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Steen, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijns, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Integrated, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaging Study, I.</span><span> </span><span class="NLM_article-title">Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.108.771899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1161%2FCIRCULATIONAHA.108.771899" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1172-1182&author=P.+W.+Serruysauthor=H.+M.+Garcia-Garciaauthor=P.+Buszmanauthor=P.+Erneauthor=S.+Verheyeauthor=M.+Aschermannauthor=H.+Duckersauthor=O.+Bleieauthor=D.+Dudekauthor=H.+E.+Botkerauthor=C.+von+Birgelenauthor=D.+D%E2%80%99Amicoauthor=T.+Hutchinsonauthor=A.+Zambaniniauthor=F.+Mastikauthor=G.+A.+van+Esauthor=A.+F.+van+der+Steenauthor=D.+G.+Vinceauthor=P.+Ganzauthor=C.+W.+Hammauthor=W.+Wijnsauthor=A.+Zalewskiauthor=B.+Integratedauthor=I.+Imaging+Study&title=Effects+of+the+direct+lipoprotein-associated+phospholipase+A%282%29+inhibitor+darapladib+on+human+coronary+atherosclerotic+plaque&doi=10.1161%2FCIRCULATIONAHA.108.771899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.108.771899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.108.771899%26sid%3Dliteratum%253Aachs%26aulast%3DSerruys%26aufirst%3DP.%2BW.%26aulast%3DGarcia-Garcia%26aufirst%3DH.%2BM.%26aulast%3DBuszman%26aufirst%3DP.%26aulast%3DErne%26aufirst%3DP.%26aulast%3DVerheye%26aufirst%3DS.%26aulast%3DAschermann%26aufirst%3DM.%26aulast%3DDuckers%26aufirst%3DH.%26aulast%3DBleie%26aufirst%3DO.%26aulast%3DDudek%26aufirst%3DD.%26aulast%3DBotker%26aufirst%3DH.%2BE.%26aulast%3Dvon%2BBirgelen%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DD.%26aulast%3DHutchinson%26aufirst%3DT.%26aulast%3DZambanini%26aufirst%3DA.%26aulast%3DMastik%26aufirst%3DF.%26aulast%3Dvan%2BEs%26aufirst%3DG.%2BA.%26aulast%3Dvan%2Bder%2BSteen%26aufirst%3DA.%2BF.%26aulast%3DVince%26aufirst%3DD.%2BG.%26aulast%3DGanz%26aufirst%3DP.%26aulast%3DHamm%26aufirst%3DC.%2BW.%26aulast%3DWijns%26aufirst%3DW.%26aulast%3DZalewski%26aufirst%3DA.%26aulast%3DIntegrated%26aufirst%3DB.%26aulast%3DImaging%2BStudy%26aufirst%3DI.%26atitle%3DEffects%2520of%2520the%2520direct%2520lipoprotein-associated%2520phospholipase%2520A%25282%2529%2520inhibitor%2520darapladib%2520on%2520human%2520coronary%2520atherosclerotic%2520plaque%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1172%26epage%3D1182%26doi%3D10.1161%2FCIRCULATIONAHA.108.771899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Stability Investigators:</p></div><span class="NLM_contrib-group">White, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Held, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budaj, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steg, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardissino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avezum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aylward, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbalan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalby, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danchin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denchev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elisaf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flather, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudev, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinfeld, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husted, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Sendon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, E. R.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pais, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhomenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos-Corrales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sereg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddique, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnaeve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sritara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swart, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viigimaa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinereanu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallentin, L.</span><span> </span><span class="NLM_article-title">Darapladib for preventing ischemic events in stable coronary heart disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1711</span><span class="refDoi"> DOI: 10.1056/NEJMoa1315878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1056%2FNEJMoa1315878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=24678955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVemsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=1702-1711&author=H.+D.+Whiteauthor=C.+Heldauthor=R.+Stewartauthor=E.+Tarkaauthor=R.+Brownauthor=R.+Y.+Daviesauthor=A.+Budajauthor=R.+A.+Harringtonauthor=P.+G.+Stegauthor=D.+Ardissinoauthor=P.+W.+Armstrongauthor=A.+Avezumauthor=P.+E.+Aylwardauthor=A.+Bryceauthor=H.+Chenauthor=M.+F.+Chenauthor=R.+Corbalanauthor=A.+J.+Dalbyauthor=N.+Danchinauthor=R.+J.+De+Winterauthor=S.+Denchevauthor=R.+Diazauthor=M.+Elisafauthor=M.+D.+Flatherauthor=A.+R.+Goudevauthor=C.+B.+Grangerauthor=L.+Grinfeldauthor=J.+S.+Hochmanauthor=S.+Hustedauthor=H.+S.+Kimauthor=W.+Koenigauthor=A.+Linhartauthor=E.+Lonnauthor=J.+Lopez-Sendonauthor=A.+J.+Manolisauthor=E.+R.+Mohlerauthor=J.+C.+Nicolauauthor=P.+Paisauthor=A.+Parkhomenkoauthor=T.+R.+Pedersenauthor=D.+Pellaauthor=M.+A.+Ramos-Corralesauthor=M.+Rudaauthor=M.+Seregauthor=S.+Siddiqueauthor=P.+Sinnaeveauthor=P.+Smithauthor=P.+Sritaraauthor=H.+P.+Swartauthor=R.+G.+Syauthor=T.+Teramotoauthor=H.+F.+Tseauthor=D.+Watsonauthor=W.+D.+Weaverauthor=R.+Weissauthor=M.+Viigimaaauthor=D.+Vinereanuauthor=J.+Zhuauthor=C.+P.+Cannonauthor=L.+Wallentin&title=Darapladib+for+preventing+ischemic+events+in+stable+coronary+heart+disease&doi=10.1056%2FNEJMoa1315878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Darapladib for preventing ischemic events in stable coronary heart disease</span></div><div class="casAuthors">White, Harvey D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1702-1711</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Elevated lipoprotein-assocd. phospholipase A2 activity promotes the development of vulnerable atherosclerotic plaques, and elevated plasma levels of this enzyme are assocd. with an increased risk of coronary events.  Darapladib is a selective oral inhibitor of lipoprotein-assocd. phospholipase A2.  Methods: In a double-blind trial, we randomly assigned 15,828 patients with stable coronary heart disease to receive either once-daily darapladib (at a dose of 160 mg) or placebo.  The primary end point was the time to cardiovascular death, myocardial infarction, or stroke.  Secondary end points included the components of the primary end point as well as major coronary events (death from coronary heart disease, myocardial infarction, or urgent coronary revascularization for myocardial ischemia) and total coronary events (death from coronary heart disease, myocardial infarction, hospitalization for unstable angina, or any coronary revascularization).  Results: During a median follow-up period of 3.7 years, the primary end point occurred in 769 of 7924 patients (9.7%) in the darapladib group and 819 of 7904 patients (10.4%) in the placebo group (hazard ratio in the darapladib group, 0.94; 95% confidence interval [CI], 0.85 to 1.03; P = 0.20).  There were also no significant between-group differences in the rates of the individual components of the primary end point or in all-cause mortality.  Darapladib, as compared with placebo, reduced the rate of major coronary events (9.3% vs. 10.3%; hazard ratio, 0.90; 95% CI, 0.82 to 1.00; P = 0.045) and total coronary events (14.6% vs. 16.1%; hazard ratio, 0.91; 95% CI, 0.84 to 0.98; P = 0.02).  Conclusions: In patients with stable coronary heart disease, darapladib did not significantly reduce the risk of the primary composite end point of cardiovascular death, myocardial infarction, or stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEBKCDjmul8rVg90H21EOLACvtfcHk0liQ52Y-sXq4kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVemsbo%253D&md5=b53dfaab74ff4e029a99bfe054bf4a95</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1315878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1315878%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DH.%2BD.%26aulast%3DHeld%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DR.%26aulast%3DTarka%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DR.%2BY.%26aulast%3DBudaj%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26aulast%3DSteg%26aufirst%3DP.%2BG.%26aulast%3DArdissino%26aufirst%3DD.%26aulast%3DArmstrong%26aufirst%3DP.%2BW.%26aulast%3DAvezum%26aufirst%3DA.%26aulast%3DAylward%26aufirst%3DP.%2BE.%26aulast%3DBryce%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DM.%2BF.%26aulast%3DCorbalan%26aufirst%3DR.%26aulast%3DDalby%26aufirst%3DA.%2BJ.%26aulast%3DDanchin%26aufirst%3DN.%26aulast%3DDe%2BWinter%26aufirst%3DR.%2BJ.%26aulast%3DDenchev%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DR.%26aulast%3DElisaf%26aufirst%3DM.%26aulast%3DFlather%26aufirst%3DM.%2BD.%26aulast%3DGoudev%26aufirst%3DA.%2BR.%26aulast%3DGranger%26aufirst%3DC.%2BB.%26aulast%3DGrinfeld%26aufirst%3DL.%26aulast%3DHochman%26aufirst%3DJ.%2BS.%26aulast%3DHusted%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKoenig%26aufirst%3DW.%26aulast%3DLinhart%26aufirst%3DA.%26aulast%3DLonn%26aufirst%3DE.%26aulast%3DLopez-Sendon%26aufirst%3DJ.%26aulast%3DManolis%26aufirst%3DA.%2BJ.%26aulast%3DMohler%26aufirst%3DE.%2BR.%26aulast%3DNicolau%26aufirst%3DJ.%2BC.%26aulast%3DPais%26aufirst%3DP.%26aulast%3DParkhomenko%26aufirst%3DA.%26aulast%3DPedersen%26aufirst%3DT.%2BR.%26aulast%3DPella%26aufirst%3DD.%26aulast%3DRamos-Corrales%26aufirst%3DM.%2BA.%26aulast%3DRuda%26aufirst%3DM.%26aulast%3DSereg%26aufirst%3DM.%26aulast%3DSiddique%26aufirst%3DS.%26aulast%3DSinnaeve%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DSritara%26aufirst%3DP.%26aulast%3DSwart%26aufirst%3DH.%2BP.%26aulast%3DSy%26aufirst%3DR.%2BG.%26aulast%3DTeramoto%26aufirst%3DT.%26aulast%3DTse%26aufirst%3DH.%2BF.%26aulast%3DWatson%26aufirst%3DD.%26aulast%3DWeaver%26aufirst%3DW.%2BD.%26aulast%3DWeiss%26aufirst%3DR.%26aulast%3DViigimaa%26aufirst%3DM.%26aulast%3DVinereanu%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DCannon%26aufirst%3DC.%2BP.%26aulast%3DWallentin%26aufirst%3DL.%26atitle%3DDarapladib%2520for%2520preventing%2520ischemic%2520events%2520in%2520stable%2520coronary%2520heart%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D1702%26epage%3D1711%26doi%3D10.1056%2FNEJMoa1315878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Maher-Edwards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De’Ath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, A.</span><span> </span><span class="NLM_article-title">A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia: Transl. Res. Clin. Interventions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.trci.2015.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.trci.2015.06.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=131-140&author=G.+Maher-Edwardsauthor=J.+De%E2%80%99Athauthor=C.+Barnettauthor=A.+Lavrovauthor=A.+Lockhart&title=A+24-week+study+to+evaluate+the+effect+of+rilapladib+on+cognition+and+cerebrospinal+fluid+biomarkers+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.trci.2015.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaher-Edwards%26aufirst%3DG.%26aulast%3DDe%25E2%2580%2599Ath%26aufirst%3DJ.%26aulast%3DBarnett%26aufirst%3DC.%26aulast%3DLavrov%26aufirst%3DA.%26aulast%3DLockhart%26aufirst%3DA.%26atitle%3DA%252024-week%2520study%2520to%2520evaluate%2520the%2520effect%2520of%2520rilapladib%2520on%2520cognition%2520and%2520cerebrospinal%2520fluid%2520biomarkers%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%253A%2520Transl.%2520Res.%2520Clin.%2520Interventions%26date%3D2015%26volume%3D1%26spage%3D131%26epage%3D140%26doi%3D10.1016%2Fj.trci.2015.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">Recombinant human Lp-PLA<sub>2</sub> Thio-PAF assay. This is the primary Lp-PLA<sub>2</sub> bioassay that was employed to measure inhibition in of Lp-PLA<sub>2</sub>. It is a fluorescence intensity assay using Thio-Paf. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Recombinant human Lp-PLA<sub>2</sub> human plasma Thio-PAF assay. It is a secondary assay (also using Thio-Paf) that measures the inhibition of Lp-PLA<sub>2</sub> in whole human plasma. This assay functions to assess nonspecific binding events of inhibitors in plasma and approximates the physiological environment of the enzyme. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Shaddinger, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roger, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macphee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baidoo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepore, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprecher, D. L.</span><span> </span><span class="NLM_article-title">Platelet aggregation unchanged by lipoprotein-associated phospholipase A(2) inhibition: results from an in vitro study and two randomized phase I trials</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83094</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1371%2Fjournal.pone.0083094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e83094&author=B.+C.+Shaddingerauthor=Y.+Xuauthor=J.+H.+Rogerauthor=C.+H.+Macpheeauthor=M.+Handelauthor=C.+A.+Baidooauthor=M.+Mageeauthor=J.+J.+Leporeauthor=D.+L.+Sprecher&title=Platelet+aggregation+unchanged+by+lipoprotein-associated+phospholipase+A%282%29+inhibition%3A+results+from+an+in+vitro+study+and+two+randomized+phase+I+trials&doi=10.1371%2Fjournal.pone.0083094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083094%26sid%3Dliteratum%253Aachs%26aulast%3DShaddinger%26aufirst%3DB.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DRoger%26aufirst%3DJ.%2BH.%26aulast%3DMacphee%26aufirst%3DC.%2BH.%26aulast%3DHandel%26aufirst%3DM.%26aulast%3DBaidoo%26aufirst%3DC.%2BA.%26aulast%3DMagee%26aufirst%3DM.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DSprecher%26aufirst%3DD.%2BL.%26atitle%3DPlatelet%2520aggregation%2520unchanged%2520by%2520lipoprotein-associated%2520phospholipase%2520A%25282%2529%2520inhibition%253A%2520results%2520from%2520an%2520in%2520vitro%2520study%2520and%2520two%2520randomized%2520phase%2520I%2520trials%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De83094%26doi%3D10.1371%2Fjournal.pone.0083094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of imidazo[1,2-a]pyrimidine derivatives as potent and orally bioavailable lipoprotein-associated phospholipase A2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8529</span><span class="NLM_x">–</span> <span class="NLM_lpage">8541</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8529-8541&author=X.+Chenauthor=W.+Xuauthor=K.+Wangauthor=M.+Moauthor=W.+Zhangauthor=L.+Duauthor=X.+Yuanauthor=Y.+Xuauthor=Y.+Wangauthor=J.+Shen&title=Discovery+of+a+novel+series+of+imidazo%5B1%2C2-a%5Dpyrimidine+derivatives+as+potent+and+orally+bioavailable+lipoprotein-associated+phospholipase+A2+inhibitors&doi=10.1021%2Facs.jmedchem.5b01024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01024%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DMo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520imidazo%255B1%252C2-a%255Dpyrimidine%2520derivatives%2520as%2520potent%2520and%2520orally%2520bioavailable%2520lipoprotein-associated%2520phospholipase%2520A2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8529%26epage%3D8541%26doi%3D10.1021%2Facs.jmedchem.5b01024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nagano, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speers, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Vega, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A<sub>2</sub></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2012.11.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=839-843&author=J.+M.+G.+Naganoauthor=K.-L.+Hsuauthor=L.+R.+Whitbyauthor=M.+J.+Niphakisauthor=A.+E.+Speersauthor=S.+J.+Brownauthor=T.+Spicerauthor=V.+Fernandez-Vegaauthor=J.+Fergusonauthor=P.+Hodderauthor=P.+Srinivasanauthor=T.+D.+Gonzalezauthor=H.+Rosenauthor=B.+J.+Bahnsonauthor=B.+F.+Cravatt&title=Selective+inhibitors+and+tailored+activity+probes+for+lipoprotein-associated+phospholipase+A2&doi=10.1016%2Fj.bmcl.2012.11.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.061%26sid%3Dliteratum%253Aachs%26aulast%3DNagano%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DHsu%26aufirst%3DK.-L.%26aulast%3DWhitby%26aufirst%3DL.%2BR.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DSpeers%26aufirst%3DA.%2BE.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DSpicer%26aufirst%3DT.%26aulast%3DFernandez-Vega%26aufirst%3DV.%26aulast%3DFerguson%26aufirst%3DJ.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DSrinivasan%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DT.%2BD.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DSelective%2520inhibitors%2520and%2520tailored%2520activity%2520probes%2520for%2520lipoprotein-associated%2520phospholipase%2520A2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D839%26epage%3D843%26doi%3D10.1016%2Fj.bmcl.2012.11.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, C. A.</span><span> </span><span class="NLM_article-title">Mechanism of inhibition of LDL phospholipase A2 by monocyclic-beta-lactams. Burst kinetics and the effect of stereochemistry</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">10087</span><span class="NLM_x">–</span> <span class="NLM_lpage">10093</span><span class="refDoi"> DOI: 10.1021/bi9801412</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9801412" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=10087-10093&author=D.+G.+Tewauthor=H.+F.+Boydauthor=S.+Ashmanauthor=C.+Theobaldauthor=C.+A.+Leach&title=Mechanism+of+inhibition+of+LDL+phospholipase+A2+by+monocyclic-beta-lactams.+Burst+kinetics+and+the+effect+of+stereochemistry&doi=10.1021%2Fbi9801412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fbi9801412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9801412%26sid%3Dliteratum%253Aachs%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DBoyd%26aufirst%3DH.%2BF.%26aulast%3DAshman%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DC.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26atitle%3DMechanism%2520of%2520inhibition%2520of%2520LDL%2520phospholipase%2520A2%2520by%2520monocyclic-beta-lactams.%2520Burst%2520kinetics%2520and%2520the%2520effect%2520of%2520stereochemistry%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D10087%26epage%3D10093%26doi%3D10.1021%2Fbi9801412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Jeong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. S.</span><span> </span><span class="NLM_article-title">(<i>E</i>)-Phenyl- and -heteroaryl-substituted <i>O</i>-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.11.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2004.11.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1525-1527&author=T.+S.+Jeongauthor=M.+J.+Kimauthor=H.+Yuauthor=K.+S.+Kimauthor=J.+K.+Choiauthor=S.+S.+Kimauthor=W.+S.+Lee&title=%28E%29-Phenyl-+and+-heteroaryl-substituted+O-benzoyl-%28or+acyl%29oximes+as+lipoprotein-associated+phospholipase+A2+inhibitors&doi=10.1016%2Fj.bmcl.2004.11.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.11.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.11.063%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DT.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3D%2528E%2529-Phenyl-%2520and%2520-heteroaryl-substituted%2520O-benzoyl-%2528or%2520acyl%2529oximes%2520as%2520lipoprotein-associated%2520phospholipase%2520A2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1525%26epage%3D1527%26doi%3D10.1016%2Fj.bmcl.2004.11.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Jeong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. S.</span><span> </span><span class="NLM_article-title">Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde <i>O</i>-heterocycle-4-carbonyloxime</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5576</span><span class="NLM_x">–</span> <span class="NLM_lpage">5579</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2006.08.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5576-5579&author=H.+J.+Jeongauthor=Y.+D.+Parkauthor=H.+Y.+Parkauthor=I.+Y.+Jeongauthor=T.+S.+Jeongauthor=W.+S.+Lee&title=Potent+inhibitors+of+lipoprotein-associated+phospholipase+A%282%29%3A+benzaldehyde+O-heterocycle-4-carbonyloxime&doi=10.1016%2Fj.bmcl.2006.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DY.%2BD.%26aulast%3DPark%26aufirst%3DH.%2BY.%26aulast%3DJeong%26aufirst%3DI.%2BY.%26aulast%3DJeong%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3DPotent%2520inhibitors%2520of%2520lipoprotein-associated%2520phospholipase%2520A%25282%2529%253A%2520benzaldehyde%2520O-heterocycle-4-carbonyloxime%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5576%26epage%3D5579%26doi%3D10.1016%2Fj.bmcl.2006.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Lin, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amantea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cajica, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreder, K. R.</span><span> </span><span class="NLM_article-title">Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2011.12.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=868-871&author=E.+C.+Linauthor=Y.+Huauthor=C.+M.+Amanteaauthor=L.+M.+Phamauthor=J.+Cajicaauthor=E.+Okerbergauthor=H.+E.+Brownauthor=A.+Fraserauthor=L.+Duauthor=Y.+Kohnoauthor=J.+Ishiyamaauthor=J.+W.+Kozarichauthor=K.+R.+Shreder&title=Amides+of+xanthurenic+acid+as+zinc-dependent+inhibitors+of+Lp-PLA%282%29&doi=10.1016%2Fj.bmcl.2011.12.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DE.%2BC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DAmantea%26aufirst%3DC.%2BM.%26aulast%3DPham%26aufirst%3DL.%2BM.%26aulast%3DCajica%26aufirst%3DJ.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DH.%2BE.%26aulast%3DFraser%26aufirst%3DA.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DIshiyama%26aufirst%3DJ.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26aulast%3DShreder%26aufirst%3DK.%2BR.%26atitle%3DAmides%2520of%2520xanthurenic%2520acid%2520as%2520zinc-dependent%2520inhibitors%2520of%2520Lp-PLA%25282%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D868%26epage%3D871%26doi%3D10.1016%2Fj.bmcl.2011.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cajica, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amantea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreder, K. R.</span><span> </span><span class="NLM_article-title">Amides of 4-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic acid as zinc-dependent inhibitors of Lp-PLA(2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1553</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2Fj.bmcl.2012.11.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1553-1556&author=Y.+Huauthor=E.+C.+Linauthor=L.+M.+Phamauthor=J.+Cajicaauthor=C.+M.+Amanteaauthor=E.+Okerbergauthor=H.+E.+Brownauthor=A.+Fraserauthor=L.+Duauthor=Y.+Kohnoauthor=J.+Ishiyamaauthor=J.+W.+Kozarichauthor=K.+R.+Shreder&title=Amides+of+4-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic+acid+as+zinc-dependent+inhibitors+of+Lp-PLA%282%29&doi=10.1016%2Fj.bmcl.2012.11.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DE.%2BC.%26aulast%3DPham%26aufirst%3DL.%2BM.%26aulast%3DCajica%26aufirst%3DJ.%26aulast%3DAmantea%26aufirst%3DC.%2BM.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DH.%2BE.%26aulast%3DFraser%26aufirst%3DA.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DIshiyama%26aufirst%3DJ.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26aulast%3DShreder%26aufirst%3DK.%2BR.%26atitle%3DAmides%2520of%25204-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic%2520acid%2520as%2520zinc-dependent%2520inhibitors%2520of%2520Lp-PLA%25282%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1553%26epage%3D1556%26doi%3D10.1016%2Fj.bmcl.2012.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery of potent and orally active lipoprotein-associated phospholipase A2 (Lp-PLA<sub>2</sub>) inhibitors as a potential therapy for diabetic macular edema</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2687</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01930</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01930" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2674-2687&author=X.+Chenauthor=K.+Wangauthor=W.+Xuauthor=Q.+Maauthor=M.+Chenauthor=L.+Duauthor=M.+Moauthor=Y.+Wangauthor=J.+Shen&title=Discovery+of+potent+and+orally+active+lipoprotein-associated+phospholipase+A2+%28Lp-PLA2%29+inhibitors+as+a+potential+therapy+for+diabetic+macular+edema&doi=10.1021%2Facs.jmedchem.5b01930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14hR"><div class="casContent"><span class="casTitleNuber">14h</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema</span></div><div class="casAuthors">Chen, Xinde; Wang, Kai; Xu, Wenwei; Ma, Quanxin; Chen, Minli; Du, Lili; Mo, Mingguang; Wang, Yiping; Shen, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2674-2687</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoprotein-assocd. phospholipase A2 (Lp-PLA2) is considered to be a promising therapeutic target for several inflammation-assocd. diseases.  Herein, the authors describe the discovery of a series of pyrimidone derivs. as Lp-PLA2 inhibitors.  Systematic structural modifications led to the identification of several pyrimidone compds. with promising in vitro inhibitory potency and pharmacokinetic properties.  Compd. 2-(4-chloro-3-(trifluoromethyl)phenoxy)-5-(((1-methyl-6-morpholino-2-oxo-1,2-dihydropyrimidin-4-yl)oxy)methyl)benzonitrile (14c), selected for in vivo evaluation, demonstrated decent pharmacokinetic profiles and robust inhibitory potency against Lp-PLA2 in Sprague-Dawley (SD) rats.  Furthermore, (14c) significantly inhibited retinal thickening in STZ-induced diabetic SD rats as a model of diabetic macular edema (DME) after oral dosing for 4 wk.  Taken together, these results suggested that (14c) can serve as a valuable lead in the search for new Lp-PLA2 inhibitors for prevention and/or treatment of DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU6PK5PQKNZbVg90H21EOLACvtfcHk0lgPt0IwwPGdSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ynsL4%253D&md5=806cea713a349bfea27e3ecb9503d2ca</span></div><a href="/servlet/linkout?suffix=cit14h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01930%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DMo%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520orally%2520active%2520lipoprotein-associated%2520phospholipase%2520A2%2520%2528Lp-PLA2%2529%2520inhibitors%2520as%2520a%2520potential%2520therapy%2520for%2520diabetic%2520macular%2520edema%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2674%26epage%3D2687%26doi%3D10.1021%2Facs.jmedchem.5b01930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Samanta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnson, B. J.</span><span> </span><span class="NLM_article-title">Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">31617</span><span class="NLM_x">–</span> <span class="NLM_lpage">31624</span><span class="refDoi"> DOI: 10.1074/jbc.M804750200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1074%2Fjbc.M804750200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=31617-31624&author=U.+Samantaauthor=B.+J.+Bahnson&title=Crystal+structure+of+human+plasma+platelet-activating+factor+acetylhydrolase%3A+structural+implication+to+lipoprotein+binding+and+catalysis&doi=10.1074%2Fjbc.M804750200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M804750200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M804750200%26sid%3Dliteratum%253Aachs%26aulast%3DSamanta%26aufirst%3DU.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520human%2520plasma%2520platelet-activating%2520factor%2520acetylhydrolase%253A%2520structural%2520implication%2520to%2520lipoprotein%2520binding%2520and%2520catalysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D31617%26epage%3D31624%26doi%3D10.1074%2Fjbc.M804750200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Woolford, A. J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aravapalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holding, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manas, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleland, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neipp, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potvain, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velagaleti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span> </span><span class="NLM_article-title">Exploitation of a novel binding pocket in human lipoprotein-associated phospholipase A2 (Lp-PLA<sub>2</sub>) discovered through X-ray fragment screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5356</span><span class="NLM_x">–</span> <span class="NLM_lpage">5367</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00212</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00212" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5356-5367&author=A.+J.-A.+Woolfordauthor=J.+E.+Peroauthor=S.+Aravapalliauthor=V.+Berdiniauthor=J.+E.+Coyleauthor=P.+J.+Dayauthor=A.+M.+Dodsonauthor=P.+Grondinauthor=F.+P.+Holdingauthor=L.+Y.+Leeauthor=P.+Liauthor=E.+S.+Manasauthor=J.+Marinoauthor=A.+C.+Martinauthor=B.+W.+McClelandauthor=R.+L.+McMenaminauthor=C.+W.+Murrayauthor=C.+E.+Neippauthor=L.+W.+Pageauthor=V.+K.+Patelauthor=F.+Potvainauthor=S.+Richauthor=R.+A.+Riveroauthor=K.+Smithauthor=D.+O.+Somersauthor=L.+Trottetauthor=R.+Velagaletiauthor=G.+Williamsauthor=R.+Xie&title=Exploitation+of+a+novel+binding+pocket+in+human+lipoprotein-associated+phospholipase+A2+%28Lp-PLA2%29+discovered+through+X-ray+fragment+screening&doi=10.1021%2Facs.jmedchem.6b00212"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00212%26sid%3Dliteratum%253Aachs%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DAravapalli%26aufirst%3DS.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDodson%26aufirst%3DA.%2BM.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DHolding%26aufirst%3DF.%2BP.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DMarino%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%2BC.%26aulast%3DMcCleland%26aufirst%3DB.%2BW.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DNeipp%26aufirst%3DC.%2BE.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DRich%26aufirst%3DS.%26aulast%3DRivero%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DVelagaleti%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DR.%26atitle%3DExploitation%2520of%2520a%2520novel%2520binding%2520pocket%2520in%2520human%2520lipoprotein-associated%2520phospholipase%2520A2%2520%2528Lp-PLA2%2529%2520discovered%2520through%2520X-ray%2520fragment%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5356%26epage%3D5367%26doi%3D10.1021%2Facs.jmedchem.6b00212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of protein-ligand interactions formed between lipoprotein-associated phospholipase A2 and inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5115</span><span class="NLM_x">–</span> <span class="NLM_lpage">5120</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5115-5120&author=Q.+Liuauthor=X.+Chenauthor=W.+Chenauthor=X.+Yuanauthor=H.+Suauthor=J.+Shenauthor=Y.+Xu&title=Structural+and+thermodynamic+characterization+of+protein-ligand+interactions+formed+between+lipoprotein-associated+phospholipase+A2+and+inhibitors&doi=10.1021%2Facs.jmedchem.6b00282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of Protein-Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors</span></div><div class="casAuthors">Liu, Qiufeng; Chen, Xinde; Chen, Wuyan; Yuan, Xiaojing; Su, Haixia; Shen, Jianhua; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5115-5120</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoprotein-assocd. phospholipase A2 (Lp-PLA2) represents a promising therapeutic target for atherosclerosis and Alzheimer's disease.  Here we reported the first crystal structures of Lp-PLA2 bound with reversible inhibitors and the thermodn. characterization of complexes.  High rigidity of Lp-PLA2 structure and similar binding modes of inhibitors with completely different scaffolds are revealed.  It not only provides the mol. basis for inhibitory activity but also sheds light on the essential features of Lp-PLA2 recognition with reversible inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrT-MldsDJs7Vg90H21EOLACvtfcHk0lgPt0IwwPGdSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL4%253D&md5=a929a163f8dc8652f790736f5c3bd0ac</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00282%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520protein-ligand%2520interactions%2520formed%2520between%2520lipoprotein-associated%2520phospholipase%2520A2%2520and%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5115%26epage%3D5120%26doi%3D10.1021%2Facs.jmedchem.6b00282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">SB-480848. GlaxoSmithKline</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=348-351&author=D.+P.+Rotella&title=SB-480848.+GlaxoSmithKline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DSB-480848.%2520GlaxoSmithKline%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D348%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span>CLOGP, v4.93, <span class="NLM_publisher-name">Daylight Chemical Information Systems, Inc.</span>: <span class="NLM_publisher-loc">Laguna Niguel, CA</span>. <a href="http://www.daylight.com/dayhtml/doc/clogp/" class="extLink">http://www.daylight.com/dayhtml/doc/clogp/</a> (accessed 26th October,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CLOGP%2C+v4.93%2C+Daylight+Chemical+Information+Systems%2C+Inc.%3A+Laguna+Niguel%2C+CA.+http%3A%2F%2Fwww.daylight.com%2Fdayhtml%2Fdoc%2Fclogp%2F+%28accessed+26th+October%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCLOGP%26pub%3DDaylight%2520Chemical%2520Information%2520Systems%252C%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0ljk-TarJjubNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wenlock, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">A comparison of physiochemical property profiles of development and marketed oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span><span class="refDoi"> DOI: 10.1021/jm021053p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&author=M.+C.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+comparison+of+physiochemical+property+profiles+of+development+and+marketed+oral+drugs&doi=10.1021%2Fjm021053p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0ljk-TarJjubNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520comparison%2520of%2520physiochemical%2520property%2520profiles%2520of%2520development%2520and%2520marketed%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1250%26epage%3D1256%26doi%3D10.1021%2Fjm021053p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0ljk-TarJjubNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Recombinant human Lp-PLA<sub>2</sub> PED6 assay using a PED6 fluorogenic substrate (employed for the weaker inhibitors). See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lhZ57A9QB-DmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">Ligand efficiency (LE) = – Δ<i>G</i>/HAC ≈ −<i>RT</i> ln(IC<sub>50</sub>)/HAC (units = kcal mol<sup>–1</sup> per heavy atom).</p></div><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZgY_NeF-aRO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">Group efficiency (GE) = −ΔΔ<i>G</i>/ΔHAC (units = kcal mol<sup>–1</sup> per non-hydrogen atom).</p></div><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">Group efficiency: a guideline for hits-to-leads chemistry</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span><span class="refDoi"> DOI: 10.1002/cmdc.200800132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;key=10.1002%2Fcmdc.200800132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1179-1180&author=M.+L.+Verdonkauthor=D.+C.+Rees&title=Group+efficiency%3A+a+guideline+for+hits-to-leads+chemistry&doi=10.1002%2Fcmdc.200800132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800132%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DGroup%2520efficiency%253A%2520a%2520guideline%2520for%2520hits-to-leads%2520chemistry%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1179%26epage%3D1180%26doi%3D10.1002%2Fcmdc.200800132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAN','PDB','5JAN'); return false;">PDB: 5JAN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAH','PDB','5JAH'); return false;">PDB: 5JAH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ2','PDB','5LZ2'); return false;">PDB: 5LZ2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYY','PDB','5LYY'); return false;">PDB: 5LYY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ4','PDB','5LZ4'); return false;">PDB: 5LZ4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ5','PDB','5LZ5'); return false;">PDB: 5LZ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ7','PDB','5LZ7'); return false;">PDB: 5LZ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ8','PDB','5LZ8'); return false;">PDB: 5LZ8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ9','PDB','5LZ9'); return false;">PDB: 5LZ9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01427">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26233"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01427">10.1021/acs.jmedchem.6b01427</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Biophysical assay protocols, supplementary tables, crystallographic details, in vitro assay details, PK details, synthetic schemes, experimental procedures, and characterization of organic molecules (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_001.pdf">jm6b01427_si_001.pdf (2.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01427/suppl_file/jm6b01427_si_002.csv">jm6b01427_si_002.csv (2.27 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates for the Lp-PLA<sub>2</sub> complexes with compounds <b>2</b>–<b>5</b>, <b>13</b>, <b>(<i><b>S</b></i>)-15</b>, <b>(</b><i><b>R</b></i><b>)-15</b>, <b>(±)-18</b>, and <b>(</b><i><b>S</b></i><b>)-23</b> have been deposited in the Protein Data Bank (PDB) under accession codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAN">5JAN</a> (<b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JAH">5JAH</a> (<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ2">5LZ2</a> (<b>4</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYY">5LYY</a> (<b>5</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ4">5LZ4</a> (<b>13</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ5">5LZ5</a> (<b>(</b><i><b>S</b></i><b>)-15</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ7">5LZ7</a> (<b>(</b><i><b>R</b></i><b>)-15</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ8">5LZ8</a> (<b>(±)-18</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LZ9">5LZ9</a> (<b>(</b><i><b>S</b></i><b>)-23</b>). We will release the atomic coordinates in experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01427%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-23%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01427" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799633c69e224b2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
